Processing 00000000.tx.1: Endothelial Progenitor Cell Dysfunction A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes Cindy J.M. 

Phrase: "Endothelial Progenitor Cell Dysfunction"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   902   C0856169:endothelial dysfunction [Disease or Syndrome]
   812   C0031847:dysfunction [Functional Concept]
   812   C0277785:Dysfunction, NOS [Qualitative Concept]
   756 E C0231174:Malfunction [Functional Concept]
   756 E C1881681:MALFUNCTION [Phenomenon or Process]
   708   C0225336:Endothelial cell [Cell]

Phrase: "A Novel Concept in the Pathogenesis of Vascular Complications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0178566:concept [Idea or Concept]

Phrase: "of Type 1 Diabetes Cindy J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.2: Loomans1, Eelco J.P. de Koning1, Frank J.T. 

Phrase: "Loomans1,"

Phrase: "Eelco J.P. de Koning1,"

Phrase: "Frank J.T."
Processing 00000000.tx.3: Staal2, Maarten B. 

Phrase: "Staal2,"

Phrase: "Maarten B."
Processing 00000000.tx.4: Rookmaaker1, Caroline Verseyden1, Hetty C. de Boer1, Marianne C. 

Phrase: "Rookmaaker1,"

Phrase: "Caroline Verseyden1,"

Phrase: "Hetty C. de Boer1,"

Phrase: "Marianne C."
Processing 00000000.tx.5: Verhaar1, Branko Braam3, Ton J. 

Phrase: "Verhaar1,"

Phrase: "Branko Braam3,"

Phrase: "Ton J."
Processing 00000000.tx.6: Rabelink1, and Anton-Jan van Zonneveld1 1 Department of Vascular Medicine and Diabetology, University Medical Center Utrecht, Utrecht, the Netherlands 2 Department of Immunology, Erasmus Medical Center, Rotterdam, the Netherlands 3 Department of Nephology, University Medical Center Utrecht, Utrecht, the Netherlands  ABSTRACT TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Type 1 diabetes is associated with reduced vascular repair, as indicated by impaired wound healing and reduced collateral formation in ischemia. 

Phrase: "Rabelink1,"

Phrase: "and"

Phrase: "Anton-Jan van Zonneveld1 1 Department of Vascular Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Diabetology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441552:Diabetology [Diagnostic Procedure]

Phrase: "University Medical Center Utrecht,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]

Phrase: "Utrecht,"

Phrase: "the Netherlands 2 Department of Immunology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "Erasmus Medical Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]

Phrase: "Rotterdam,"

Phrase: "the Netherlands 3 Department of Nephology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "University Medical Center Utrecht,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]

Phrase: "Utrecht,"

Phrase: "the Netherlands  ABSTRACT TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0035171:Research Design [Research Activity]
   795   C0035168:research [Research Activity]
   795   C0242481:Research [Research Activity]
   795   C1707689:Design [Activity]
   795   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "associated with reduced vascular repair,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C2364034:blood vessel repair [Therapeutic or Preventive Procedure]
   760   C0005847:vascular [Body Part, Organ, or Organ Component]
   760   C0043240:Repair, NOS [Organism Function]
   760   C0374711:Repair [Therapeutic or Preventive Procedure]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1558950:VASCULAR [Finding]
   760   C1801960:Vascular [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   704 E C1511228:VESSEL, BLOOD [Tissue]

Phrase: "as"

Phrase: "indicated by impaired wound healing"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   862   C0151692:Impaired wound healing [Pathologic Function]
           HEALING IMPAIRED
   806   C0043240:Wound Healing [Organism Function]
           Healing
   797 E C0574776:healing wound [Finding]
   797 E C1265679:healing wound [Anatomical Abnormality]
   760   C0043250:Wound [Injury or Poisoning]
   760   C0205249:Healing [Functional Concept]
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C1444656:Indicated [Finding]
   726 E C0016204:Wind NOS [Sign or Symptom]
   726 E C0043187:Wind [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "reduced collateral formation in ischemia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.7: Recently, endothelial progenitor cells (EPCs) have been identified as important regulators of these processes. 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "endothelial progenitor cells (EPCs)"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "identified as important regulators of these processes."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0182953:regulators [Medical Device]
   748   C0205396:Identified [Qualitative Concept]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   714   C1184743:Process [Body Part, Organ, or Organ Component]
   714   C1522240:Process [Phenomenon or Process]
   714 E C1704734:Regulator [Medical Device]
   714 E C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.8: We therefore explored the concept that EPCs are dysfunctional in diabetes. 

Phrase: "We therefore"

Phrase: "explored"

Phrase: "the concept"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178566:concept [Idea or Concept]

Phrase: "that EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "dysfunctional in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   718   C0031847:dysfunction [Functional Concept]
   718   C0277785:Dysfunction, NOS [Qualitative Concept]
Processing 00000000.tx.9: The number of EPCs obtained from type 1 diabetic patients in culture was 44% lower compared with age- and sex-matched control subjects (P < 0.001). 

Phrase: "The number of EPCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "obtained from type 1 diabetic patients"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0441729:Type 1 [Classification]
   767   C1550335:Patient type [Classification]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1547052:*Type [Quantitative Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "in culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "was"

Phrase: "44% lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441994:Lower [Spatial Concept]
   861   C1548802:Lower [Body Location or Region]
   861   C2003888:Lower [Activity]

Phrase: "compared with age-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0001779:Age [Organism Attribute]
   790   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "sex-matched control subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "(P < 0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.10: This reduction was inversely related to levels of HbA1c (R = -0.68, P = 0.01). 

Phrase: "This reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0301630:Reduction [Natural Phenomenon or Process]
  1000   C0392756:Reduction [Qualitative Concept]
  1000   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "inversely"

Phrase: "related to levels of HbA1c"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0439849:Related [Qualitative Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "(R = -0.68,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205090:R- [Spatial Concept]
   827   C0450387:68 [Intellectual Product]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P = 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.11: In addition, we demonstrated that patient EPCs were also impaired in function using an in vitro angiogenesis assay. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that patient EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   875   C0225336:Endothelial Cells [Cell]
   861   C0038250:Progenitor Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C0870134:Progenitor [Family Group]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "also"

Phrase: "impaired in function"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0031843:function [Physiologic Function]
   790   C0221099:Impaired [Functional Concept]
   790   C0542341:Function [Functional Concept]
   790   C0684336:Impaired [Pathologic Function]
   790   C0700205:FUNCTION [Classification]
   790   C1705273:Function [Intellectual Product]
   718 E C0205245:Functional [Functional Concept]
   718 E C2700217:Functional [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an in vitro angiogenesis assay."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1515653:In Vitro Assay [Research Activity]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.12: Conditioned media from patient EPCs were significantly reduced in their capacity to support endothelial tube formation in comparison to control EPCs. 

Phrase: "Conditioned media from patient EPCs"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   778   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   748   C0009458:Media [Intellectual Product]
   748   C0162867:Media [Tissue]
   748   C1254021:Media [Tissue]
   714 E C0439536:Medium [Quantitative Concept]
   714 E C1705217:Medium [Substance]
   714 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "significantly"

Phrase: "reduced in their capacity to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Reduced [Qualitative Concept]
   760   C1516240:Capacity [Quantitative Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "endothelial tube formation in comparison to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C2752214:tube formation [Organ or Tissue Function]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "EPCs."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.13: Therefore, despite culturing the EPCs under normoglycemic conditions, functional differences between patient and control EPCs were maintained. 

Phrase: "Therefore,"

Phrase: "despite"

Phrase: "culturing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "the EPCs under normoglycemic conditions,"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0038250:Progenitor Cells [Cell]
   774   C0225336:Endothelial Cells [Cell]
   757   C0007634:THE CELL [Cell]
           Cells
   748   C0014257:Endothelial [Tissue]
   748   C0870134:Progenitor [Family Group]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "functional differences between patient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "maintained."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]
Processing 00000000.tx.14: Our findings demonstrate that adverse metabolic stress factors in type 1 diabetes are associated with reduced EPC numbers and angiogenicity. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "demonstrate"

Phrase: "that adverse metabolic stress factors in type 1 diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1521761:Factor [Functional Concept]
   708   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "associated with reduced EPC numbers"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0169014:EPC [Organophosphorus Compound,Pharmacologic Substance]
   760   C0237753:*Number [Quantitative Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C0449788:Number [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "angiogenicity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   928   C0302600:Angiogenic [Organ or Tissue Function]
   900 E C1172713:angiogen [Pharmacologic Substance]
Processing 00000000.tx.15: We hypothesize that EPC dysfunction contributes to the pathogenesis of vascular complications in type 1 diabetes. 

Phrase: "We"

Phrase: "hypothesize"

Phrase: "that EPC dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "contributes to the pathogenesis of vascular complications"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0009566:Complications [Pathologic Function]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1171258:complications [Pathologic Function]
   748   C1558950:VASCULAR [Finding]
   748   C1801960:Vascular [Qualitative Concept]
   748   C1880177:Contribute [Activity]
   714 E C2362589:Complication [Idea or Concept]

Phrase: "in type 1 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.16: Hyperglycemia is associated with endothelial cell (EC) dysfunction and reduced neovascularization in response to tissue ischemia, processes that are essential for wound healing and prevention of cardiovascular ischemia (13). 

Phrase: "Hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "is"

Phrase: "associated with endothelial cell (EC) dysfunction"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   806   C0225336:Endothelial cell [Cell]
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0699040:cell associated [Cell Component]
   797   C0856169:endothelial dysfunction [Disease or Syndrome]
   760   C0007634:Cell [Cell]
   760   C0014257:Endothelial [Tissue]
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "reduced neovascularization in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027686:Neovascularisation [Pathologic Function]

Phrase: "to tissue ischemia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0022116:Ischaemia [Disease or Syndrome]
   789 E C0475224:Ischaemic [Functional Concept]

Phrase: "processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "are"

Phrase: "essential for wound healing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "prevention of cardiovascular ischemia"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0199176:Prevention [Therapeutic or Preventive Procedure]
   770   C1706420:PREVENTION [Research Activity]
   770   C2700409:prevention [Qualitative Concept]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.17: A growing body of evidence indicates that neovascularization does not exclusively rely on proliferation of local ECs but also involves bone marrow-derived circulating stem cells (4). 

Phrase: "A growing body of evidence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "indicates"

Phrase: "that neovascularization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027686:Neovascularisation [Pathologic Function]

Phrase: "does"

Phrase: "not exclusively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "rely on proliferation of local ECs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0013806:ECS [Therapeutic or Preventive Procedure]
   753   C0205276:Local [Spatial Concept]
   753   C0334094:Proliferation [Pathologic Function]
   753   C1514485:Proliferation [Functional Concept]

Phrase: "but"

Phrase: "also"

Phrase: "involves"

Phrase: "bone marrow-derived circulating stem cells"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   913   C1511246:Bone Marrow Stem Cells [Cell]
   904   C0005955:Bone Marrow Cells [Cell]
   895   C0222677:Bone cells [Cell]
   878 E C0029432:Bone cell [Cell]
   827   C0038250:Stem cells [Cell]
   799   C0007634:Cells [Cell]
   799   C0242767:Stem [Plant]
   799   C1186763:Stem [Body Part, Organ, or Organ Component]
   799   C3282337:Cells [Cell]
   766 E C1269647:Cell [Cell]
   766 E C1704653:Cell [Medical Device]
   766 E C1948049:Cell [Spatial Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.18: These cells can be cultured from the circulating mononuclear cell (MNC) fraction and are commonly referred to as endothelial progenitor cells (EPCs) because they exhibit characteristic endothelial surface markers and properties. 

Phrase: "These cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "be"

Phrase: "cultured from the circulating mononuclear cell (MNC) fraction"
Meta Candidates (Total=16; Excluded=1; Pruned=0; Remaining=15)
   778   C0805525:Cell Fraction [Cell Component]
   778   C0806987:mononuclear cell [Cell]
   774   C0007635:cultured cell [Cell]
   757 E C0007585:Cell Culture [Laboratory Procedure]
   748   C0007634:Cell [Cell]
   748   C0175630:Circulating [Functional Concept]
   748   C1264633:Fraction [Quantitative Concept]
   748   C1269647:Cell [Cell]
   748   C1513475:Mononuclear [Clinical Attribute]
   748   C1554103:Fraction [Idea or Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714   C0010453:Culture [Idea or Concept]
   714   C0220814:culture [Functional Concept]
   714   C0430400:Culture [Laboratory Procedure]
   714   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "are"

Phrase: "commonly"

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "endothelial progenitor cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ")"

Phrase: "because"

Phrase: "they"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "characteristic endothelial surface markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "properties."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0871161:properties [Qualitative Concept]
  1000   C1292721:properties [Functional Concept]
   966 E C1882134:Property [Conceptual Entity]
   966 E C2347695:Property [Entity]
Processing 00000000.tx.19: Moreover, a number of studies have shown that injected EPCs home to sites of ischemia, incorporate into the newly formed capillaries, and augment neovascularization (5). 

Phrase: "Moreover,"

Phrase: "a number of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that injected EPCs home to sites of ischemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442519:Home [Conceptual Entity]

Phrase: "incorporate into the newly formed capillaries,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0006901:Capillaries [Body Part, Organ, or Organ Component]
   753   C0205431:Formed [Functional Concept]
   753   C0750546:newly [Idea or Concept]
   753   C0935624:Capillaries [Body Part, Organ, or Organ Component]
   719 E C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "neovascularization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027686:Neovascularisation [Pathologic Function]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.20: Consequently, if EPCs are critical to endothelial maintenance and repair, EPC dysfunction could contribute to the pathogenesis of ischemic vascular disease. 

Phrase: "Consequently,"

Phrase: "if"

Phrase: "EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "critical to endothelial maintenance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]

Phrase: "and"

Phrase: "repair,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0043240:Repair, NOS [Organism Function]
  1000   C0374711:Repair [Therapeutic or Preventive Procedure]

Phrase: "EPC dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "could"

Phrase: "contribute to the pathogenesis of ischemic vascular disease."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0042373:Vascular disease [Disease or Syndrome]
   744   C0005847:vascular [Body Part, Organ, or Organ Component]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0475224:Ischaemic [Functional Concept]
   744   C0543483:pathogenesis [Functional Concept]
   744   C0699748:Pathogenesis [Pathologic Function]
   744   C1558950:VASCULAR [Finding]
   744   C1801960:Vascular [Qualitative Concept]
   744   C1880177:Contribute [Activity]
   720 E C0018939:Blood disease NOS [Disease or Syndrome]
   720 E C1533163:Blood disease [Disease or Syndrome]
Processing 00000000.tx.21: Indeed, studies have demonstrated that, in patients with cardiovascular risk factors, the number of EPCs that can be isolated from peripheral blood is reduced (6) and EPC function is impaired (7,8). 

Phrase: "Indeed,"

Phrase: "studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that,"

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with cardiovascular risk factors,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C0850624:cardiovascular risk factor [Disease or Syndrome]
   901   C0035648:risk factors [Quantitative Concept]
   901   C1553898:risk factors [Idea or Concept]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "the number of EPCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "isolated from peripheral blood"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   833   C0229664:peripheral blood [Body Substance]
           Blood
   791 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0205100:Peripheral [Spatial Concept]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "is"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "(6"

Phrase: ")"

Phrase: "and"

Phrase: "EPC function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "(7,"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.22: It was recently reported that a strong inverse correlation exists between the number of EPCs and the subjects combined Framingham risk factor score (9). 

Phrase: "It"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "a strong inverse correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707520:Correlation [Qualitative Concept]

Phrase: "exists between the number of EPCs"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   770   C0038250:Progenitor Cells [Cell]
   767   C0225336:Endothelial Cells [Cell]
   750   C0007584:Cell Number [Laboratory Procedure]
   744   C0007634:Cells [Cell]
   744   C0014257:Endothelial [Tissue]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C0870134:Progenitor [Family Group]
   744   C2987476:Exist [Conceptual Entity]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "combined"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]

Phrase: "Framingham risk factor score"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035648:Risk factor [Quantitative Concept]
   812   C0035647:Risk [Qualitative Concept]
   812   C0449820:Score [Quantitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.23: In addition, measurements of flow-mediated brachial-artery reactivity also revealed a significant relation between endothelial function and the number of EPCs, supporting a role for EPCs in the maintenance of endothelial integrity. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "measurements of flow-mediated brachial-artery reactivity also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0242485:measurements [Functional Concept]
   714   C0429855:Arterial measurement [Finding]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a significant relation between endothelial function"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0080103:Relation [Family Group]
   753   C0869014:relation [Social Behavior]

Phrase: "and"

Phrase: "the number of EPCs,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "a role for EPCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the maintenance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintenance [Activity]

Phrase: "of endothelial integrity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]
Processing 00000000.tx.24: In this study, we investigated the hypothesis that EPC dysfunction exists in type 1 diabetic patients. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that EPC dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "exists in type 1 diabetic patients."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0441729:Type 1 [Classification]
   767   C1550335:Patient type [Classification]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.25: To that end, we determined the number of EPCs obtained from peripheral blood of type 1 diabetic patients and its relation to glycemic control. 

Phrase: "To"

Phrase: "that end,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "we"

Phrase: "determined"

Phrase: "the number of EPCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "obtained from peripheral blood of type 1 diabetic patients"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   764   C0229664:peripheral blood [Body Substance]
           Blood
   764   C0441729:Type 1 [Classification]
   762   C0005810:blood type [Classification]
   762   C1383165:Blood Type [Clinical Attribute]
   762   C3274467:Blood Type [Diagnostic Procedure]
   745   C1550335:Patient type [Classification]
   742   C0005767:Blood [Tissue]
   742   C0005768:blood [Body Substance]
   742   C0030705:Patients [Patient or Disabled Group]
   742   C0205100:Peripheral [Spatial Concept]
   742   C0241863:DIABETIC [Finding]
   742   C0332307:Type [Qualitative Concept]
   742   C1301820:Obtained [Functional Concept]
   742   C1547052:*Type [Quantitative Concept]
   723 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   708 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "its relation to glycemic control."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0080103:Relation [Family Group]
   760   C0869014:relation [Social Behavior]
Processing 00000000.tx.26: Furthermore, we compared the capacity of patient and control EPCs to support endothelial tube formation in vitro.  

Phrase: "Furthermore,"

Phrase: "we"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "the capacity of patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1516240:Capacity [Quantitative Concept]

Phrase: "and"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "EPCs to"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   875   C0225336:Endothelial Cells [Cell]
   861   C0038250:Progenitor Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C0870134:Progenitor [Family Group]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "endothelial tube formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C2752214:tube formation [Organ or Tissue Function]
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.27: RESEARCH DESIGN AND METHODS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  After informed consent was obtained, peripheral blood samples were collected from 20 type 1 diabetic patients and 20 age- and sex-matched healthy control subjects. 

Phrase: "RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035171:Research Design [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0086912:methods research [Research Activity]
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION REFERENCES  After informed consent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   741   C2985635:Reference Result [Finding]
   714   C1514811:Reference [Idea or Concept]
   714   C1706462:Reference [Conceptual Entity]

Phrase: "was"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "peripheral blood samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0178913:blood samples [Body Substance]
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   734   C0229664:peripheral blood [Body Substance]

Phrase: "were"

Phrase: "collected from 20 type 1 diabetic patients"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0441729:Type 1 [Classification]
   757   C1550335:Patient type [Classification]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0241863:DIABETIC [Finding]
   748   C0332307:Type [Qualitative Concept]
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "20 age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex-matched healthy control subjects."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C1708335:HEALTHY SUBJECTS [Population Group]
   771   C0681850:Subject [Group]
   771   C1550501:{Subject} [Idea or Concept]
   771   C1706203:Subject [Idea or Concept]
   771   C2349001:Subject [Human]
   771   C2697811:Subject [Functional Concept]
Processing 00000000.tx.28: Patients with type 1 diabetes, diagnosed at least 1 year before entering the study, were recruited from the Department of Diabetology of the University Medical Center Utrecht. 

Phrase: "Patients with type 1 diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C1550335:Patient type [Classification]
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "diagnosed at least 1 year"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0011900:Diagnosed [Finding]
   760   C0439234:year [Temporal Concept]
   760   C0439508:/year [Temporal Concept]

Phrase: "before entering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1522196:ENTER [Functional Concept]

Phrase: "the study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "recruited from the Department of Diabetology of the University Medical Center Utrecht."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   753   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   753   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   751   C0587450:Medical department [Health Care Related Organization]
   736   C0041740:University [Manufactured Object,Organization]
   736   C0205099:Center [Spatial Concept]
   736   C0205476:Medical [Functional Concept]
   736   C1441552:Diabetology [Diagnostic Procedure]
   736   C1704729:Department [Organization]
Processing 00000000.tx.29: All patients were treated with insulin for at least 1 year. 

Phrase: "All patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "treated with insulin"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "for"

Phrase: "at least 1 year."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439234:year [Temporal Concept]
   827   C0439508:/year [Temporal Concept]
Processing 00000000.tx.30: Patients with manifest macrovascular disease were excluded. 

Phrase: "Patients with manifest macrovascular disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.31: Other exclusion criteria included smoking, alcohol abuse, liver disease, creatinine >120 mol/l, and untreated thyroid disease. 

Phrase: "Other exclusion criteria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0680251:Exclusion Criteria [Functional Concept]
   861   C0243161:criteria [Intellectual Product]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "smoking,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037369:Smoking [Individual Behavior]
  1000   C0453996:Smoking [Individual Behavior]
  1000   C1881674:SMOKING [Phenomenon or Process]

Phrase: "alcohol abuse,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0085762:Alcohol abuse [Mental or Behavioral Dysfunction]
   861   C0001962:ALCOHOL [Organic Chemical]
   861   C0001975:Alcohol [Organic Chemical,Pharmacologic Substance]
   861   C0013146:ABUSE [Mental or Behavioral Dysfunction]
   861   C0562381:Abuse [Finding]
   789 E C0687725:Alcoholic [Patient or Disabled Group]

Phrase: "liver disease,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
  1000   C0023895:Liver disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "creatinine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010294:Creatinine [Biologically Active Substance,Organic Chemical]
  1000   C1561535:Creatinine [Finding]

Phrase: ">120 mol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0347982:mol/L [Quantitative Concept]

Phrase: "and"

Phrase: "untreated thyroid disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0040128:Thyroid disease [Disease or Syndrome]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0040132:Thyroid, NOS [Body Part, Organ, or Organ Component]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.32: If patients were treated with vasoactive medication (angiotensin-converting enzyme inhibitors, statins, aspirin, nonsteroidal anti-inflammatory drugs, angiotensin II antagonists, folic acid, or vitamins), treatment was stopped at least 3 weeks before blood withdrawal. 

Phrase: "If"

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "treated with vasoactive medication"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0013227:Medication, NOS [Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   770   C1980011:Vasoactive [Qualitative Concept]
   770   C3244316:medication [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(angiotensin-converting enzyme inhibitors,"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0003015:Angiotensin-Converting Enzyme Inhibitors [Pharmacologic Substance]
  1000   C2757044:Angiotensin-converting Enzyme Inhibitors [Molecular Function]
   966 E C3536837:Angiotensin Converting Enzyme Inhibitor [Pharmacologic Substance]
   923   C0022709:Angiotensin Converting Enzyme [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   861   C0014432:Enzyme Inhibitors [Pharmacologic Substance]
   861   C1152555:enzyme inhibitors [Molecular Function]
   861   C2756995:Enzyme Inhibitors [Molecular Function]
   827 E C0919438:Enzyme Inhibitor [Pharmacologic Substance]
   812   C0003018:Angiotensin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0243077:inhibitors [Chemical Viewed Functionally]
   779 E C1999216:Inhibitor [Qualitative Concept]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "statins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0360714:Statins [Organic Chemical,Pharmacologic Substance]

Phrase: "aspirin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004057:Aspirin [Organic Chemical,Pharmacologic Substance]
   944 E C0699274:Ecotrin [Organic Chemical,Pharmacologic Substance]

Phrase: "nonsteroidal anti-inflammatory drugs,"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0003211:Nonsteroidal Anti-inflammatory Drugs [Pharmacologic Substance]
   988 E C3536840:Non-steroidal Antiinflammatory Drug [Pharmacologic Substance]
   923   C0003209:anti inflammatory drugs [Pharmacologic Substance]
           Anti-inflammatory
   861   C1515999:Anti-inflammatory [Qualitative Concept]
   812   C0013227:Drugs [Pharmacologic Substance]
   812   C0333348:Inflammatory [Functional Concept]
   779 E C1254351:Drug [Pharmacologic Substance]
   741 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   741 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   712 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "angiotensin II antagonists,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0243076:antagonists [Chemical Viewed Functionally]
   793 E C0231491:Antagonist [Organ or Tissue Function]
   734   C0003009:Angiotensin 2 [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   721 E C0680242:antagonism [Social Behavior]

Phrase: "folic acid,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0016410:Folic Acid [Organic Chemical,Pharmacologic Substance,Vitamin]
   944 E C0699377:Folvite [Organic Chemical,Vitamin]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "or"

Phrase: "vitamins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042890:Vitamins [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: ")"

Phrase: ","

Phrase: "treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "was"

Phrase: "stopped at least 3 weeks"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0439230:weeks [Temporal Concept]
   760   C1272691:stopped [Qualitative Concept]
   726 E C0332174:/week [Temporal Concept]
   726 E C1947925:Stop [Activity]
   726 E C2746065:Stop [Temporal Concept]

Phrase: "before blood withdrawal."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2349954:Withdrawal [Activity]
   861   C2825032:Withdrawal [Mental or Behavioral Dysfunction]
Processing 00000000.tx.33: Whole blood was used for assessment of HbA1c using an immunochemical method (Tina-quant; Roche/Hitache, Mannheim, Germany). 

Phrase: "Whole blood"
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
  1000   C0370231:whole blood [Body Substance]
  1000   C1546552:Blood, Whole [Intellectual Product]
  1000   C1608383:Whole Blood [Body Substance]
  1000   C1608936:Blood, Whole [Intellectual Product]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   861   C0444667:Whole [Quantitative Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "used for assessment of HbA1c"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   781   C1524063:Use of [Functional Concept]
   760   C1261322:Assessment [Health Care Activity]
   760   C1273517:used [Finding]
   760   C1516048:Assessment [Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an immunochemical method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "(Tina-quant"

Phrase: "; Roche/Hitache,"

Phrase: "Mannheim,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.34: Glucose concentrations were measured by a glucose oxidase technique. 

Phrase: "Glucose concentrations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   983   C0427743:Glucose concentration [Laboratory Procedure]
   983   C1287281:Glucose concentration [Laboratory or Test Result]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "measured by a glucose oxidase technique."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0017735:GLUCOSE OXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0444706:Measured [Qualitative Concept]
   753   C0449851:Technique [Functional Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.35: The study protocol was approved by the Ethics Committee of the University Medical Center Utrecht. 

Phrase: "The study protocol"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1507394:Study Protocol [Intellectual Product]
           Protocol
  1000   C2348563:Study Protocol [Intellectual Product]
           Protocol
   861   C0442711:Protocol [Intellectual Product]
   861   C0557651:Study [Manufactured Object]
   861   C1522729:Protocol [Intellectual Product]
   861   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "approved by the Ethics Committee of the University Medical Center Utrecht."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   775   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]
   756   C0085546:Ethics Committee [Professional or Occupational Group]
   756   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   756   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   754   C0015004:Ethics, Medical [Idea or Concept]
   738   C0015000:Ethics [Idea or Concept]
   738   C0041740:University [Manufactured Object,Organization]
   738   C0205099:Center [Spatial Concept]
   738   C0205476:Medical [Functional Concept]
   738   C0205540:Approved [Qualitative Concept]
   738   C1527243:ethics [Idea or Concept]
   738   C2699414:Committee [Group]
Processing 00000000.tx.36: EPC isolation and characterization. 

Phrase: "EPC isolation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0204727:Isolation [Therapeutic or Preventive Procedure]
   861   C0205409:Isolation [Functional Concept]
   861   C0220862:isolation [Laboratory Procedure]
   789 E C1548221:Isolated [Idea or Concept]

Phrase: "and"

Phrase: "characterization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterization [Activity]
Processing 00000000.tx.37: Peripheral blood was obtained in blood collection tubes containing EDTA (Venoject; Terumo Europe N.V., Leuven, Belgium). 

Phrase: "Peripheral blood"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
  1000   C0229664:peripheral blood [Body Substance]
           Blood
   958 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0205100:Peripheral [Spatial Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "obtained in blood collection tubes"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   862   C0184104:blood collection tubes [Medical Device]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0175730:tubes [Medical Device]
   760   C0229664:Blood [Body Substance]
   760   C1301820:Obtained [Functional Concept]
   760   C1516698:Collection [Functional Concept]
   760   C1547937:Tubes [Intellectual Product]
   760   C1704474:Tubes [Quantitative Concept]
   760   C1704814:Collection [Idea or Concept]
   726 E C1561954:tube [Conceptual Entity]
   726 E C1704730:TUBE [Medical Device]
   726 E C1706701:Obtain [Activity]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "EDTA (Venoject"

Phrase: "; Terumo Europe N.V., Leuven,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")."
Processing 00000000.tx.38: EPCs were cultured as described (10). 

Phrase: "EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured as described"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1552738:described [Idea or Concept]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.39: Briefly, MNC fractions were isolated from 60 ml whole blood by density gradient centrifugation (Histopaque 1077; Sigma, St. Louis, MO). 

Phrase: "Briefly,"

Phrase: "MNC fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0805525:Cell fractions [Cell Component]
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]
   734   C0806987:mononuclear cell [Cell]

Phrase: "were"

Phrase: "isolated from 60 ml whole blood"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0370231:whole blood [Body Substance]
   790   C1546552:Blood, Whole [Intellectual Product]
   790   C1608383:Whole Blood [Body Substance]
   790   C1608936:Blood, Whole [Intellectual Product]
   753   C0005767:Blood [Tissue]
   753   C0005768:blood [Body Substance]
   753   C0205409:Isolated [Functional Concept]
   753   C0229664:Blood [Body Substance]
   753   C0439526:/mL [Quantitative Concept]
   753   C0444667:Whole [Quantitative Concept]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "by density gradient centrifugation"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0007704:Centrifugation, Density Gradient [Laboratory Procedure]
   827   C0007703:Centrifugation [Laboratory Procedure]
   827   C0178587:density [Quantitative Concept]
   827   C0439182:% gradient [Quantitative Concept]
   827   C0812409:Gradient [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "(Histopaque 1077"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0164836:histopaque [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "; Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.40: MNCs were plated at a density of 1 x 106 cells per cm2 on six-well culture plates coated with 2% gelatin (Sigma) in M199 medium supplemented with 20% FBS (Invitrogen; Breda, the Netherlands), 0.05 mg/ml Bovine Pituitary Extract (Invitrogen), antibiotics, and 10 units/ml heparin (Leo Pharma BV, Breda, the Netherlands). 

Phrase: "MNCs"

Phrase: "were"

Phrase: "plated at a density of 1 x 106 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   745   C0162339:Cell Density [Quantitative Concept]
   745   C1166718:cells plate [Cell Component]
   742   C0007634:Cells [Cell]
   742   C0178587:density [Quantitative Concept]
   742   C3282337:Cells [Cell]
   708   C0005971:Plate [Medical Device]
   708   C1139930:plate [Medical Device]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   708   C3537155:Plate [Manufactured Object]

Phrase: "per cm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439479:cm2 [Quantitative Concept]
  1000   C0555206:CM2 [Congenital Abnormality]

Phrase: "on six-well culture plates"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0180454:culture plates [Medical Device]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C1139930:plates [Medical Device]
   812   C2242979:Culture [Laboratory Procedure]
   779 E C0005971:Plate [Medical Device]
   779 E C3537155:Plate [Manufactured Object]

Phrase: "coated with 2% gelatin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   770   C1145617:Gelatin [Food]
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "in M199 medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "supplemented with 20% FBS (Invitrogen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]

Phrase: "; Breda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2657734:Breda [Eukaryote]

Phrase: "the Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")"

Phrase: ","

Phrase: "0.05 mg/ml Bovine Pituitary Extract"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   845   C1511279:Bovine Pituitary Extract [Biologically Active Substance,Pharmacologic Substance]
   795   C2828366:Extract [Substance]

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "antibiotics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003232:Antibiotics [Antibiotic]

Phrase: "and"

Phrase: "10 units/ml heparin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0019134:Heparin [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0770546:HEPARIN [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(Leo Pharma BV,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511278:BV [Geographic Area]

Phrase: "Breda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2657734:Breda [Eukaryote]

Phrase: "the Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")."
Processing 00000000.tx.41: After 4 and 7 days of culture, EPC characteristics were confirmed on the basis of morphology and by fluorescent confocal immunohistochemistry using Ulex europaeus agglutinin (UEA)-1 (Vector, Burlingame, CA), a CD31 antibody (Dako, Glostrup, Denmark), and DiI-labeled acetylated LDL (Molecular Probes, Leiden, the Netherlands). 

Phrase: "After 4"

Phrase: "and"

Phrase: "7 days of culture,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   833   C1547085:7 days [Temporal Concept]
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "EPC characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521970:Characteristics [Qualitative Concept]

Phrase: "were"

Phrase: "confirmed on the basis of morphology"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0332437:Morphology [Qualitative Concept]
   753   C0521093:confirmed [Qualitative Concept]
   753   C0543482:morphology [Spatial Concept]
   753   C0700329:Morphology, NOS [Finding]
   753   C0700619:Morphology [Biomedical Occupation or Discipline]
   753   C0750484:Confirmed [Idea or Concept]
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]
   719 E C1456348:Confirm [Qualitative Concept]

Phrase: "and by fluorescent confocal immunohistochemistry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0021044:Immunohistochemistry [Laboratory Procedure]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1515981:And [Idea or Concept]

Phrase: "using Ulex europaeus agglutinin (UEA)-1"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   937   C0617814:Ulex europaeus agglutinin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0996858:Ulex europaeus [Plant]
   840   C3486655:ULEX EUROPAEUS [Pharmacologic Substance]
   804   C0001804:Agglutinin [Immunologic Factor]
   804   C0996857:Ulex [Plant]
   804   C1524063:Using [Functional Concept]
   771 E C0042153:use [Functional Concept]
   771 E C0457083:Use [Functional Concept]
   771 E C1947944:Use [Intellectual Product]

Phrase: "(Vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "Burlingame,"

Phrase: "CA),"

Phrase: "a CD31 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Dako,"

Phrase: "Glostrup,"

Phrase: "Denmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "DiI-"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "acetylated LDL (Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   812   C0182400:Probes [Medical Device]
   779 E C1704681:Probe [Gene or Genome]
   779 E C2347609:Probe [Chemical Viewed Functionally]
   779 E C3536729:Probe [Manufactured Object]

Phrase: "Leiden,"

Phrase: "the Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: ")."
Processing 00000000.tx.42: Flow cytometry analyses. 

Phrase: "Flow cytometry analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C0016263:Flow Cytometry [Laboratory Procedure]
Processing 00000000.tx.43: Quantitative determination of the percentage of cells undergoing apoptosis was determined using an Annexin V apoptosis detection kit (BD Biosciences Pharmingen, San Diego, CA) according to the manufacturers protocol. 

Phrase: "Quantitative determination of the percentage of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1148554:determination [Laboratory Procedure]

Phrase: "undergoing"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Annexin V apoptosis detection kit (BD Biosciences Pharmingen,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA) according to the manufacturers protocol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0050385:CA protocol [Therapeutic or Preventive Procedure]
Processing 00000000.tx.44: Briefly, fresh MNCs and EPCs, cultured for 4 days, were isolated as described. 

Phrase: "Briefly,"

Phrase: "fresh MNCs"

Phrase: "and"

Phrase: "EPCs,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "cultured for 4 days,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0439228:days [Temporal Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737 E C0332173:/day [Temporal Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C0439505:/day [Temporal Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "as"

Phrase: "described."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]
Processing 00000000.tx.45: After the recommended washing steps, 1 x 106 cells were incubated for 15 min with fluorescein isothiocyanate (FITC)-conjugated Annexin V in binding buffer (BD Biosciences) in the dark. 

Phrase: "After the recommended washing steps,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C1261552:steps [Conceptual Entity]
   793 E C1704379:Step [Functional Concept]
   793 E C1705117:Step [Quantitative Concept]
   793 E C2825408:Step [Manufactured Object]

Phrase: "1 x 106 cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated for 15 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "with fluorescein isothiocyanate (FITC)-conjugated Annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C1332095:ANNEXIN V [Gene or Genome]
   804   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in binding buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(BD Biosciences"

Phrase: ")"

Phrase: "in the dark."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332582:Dark [Qualitative Concept]
Processing 00000000.tx.46: Annexin binding was measured by flow cytometry (FACScan, BD Biosciences) within 1 h and quantified using CellQuest software (BD Biosciences). 

Phrase: "Annexin binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "measured by flow cytometry"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(FACScan,"

Phrase: "BD Biosciences"

Phrase: ")"

Phrase: "within 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "quantified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CellQuest software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(BD Biosciences"

Phrase: ")."
Processing 00000000.tx.47: Mean levels of Annexin V binding were determined using specific monocyte and lymphocyte gates in the forward-sideward scatter plots and expressed as arbitrary units of fluorescence. 

Phrase: "Mean levels of Annexin V binding"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "specific monocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0026473:Monocyte [Cell]

Phrase: "and"

Phrase: "lymphocyte"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024264:Lymphocyte [Cell]

Phrase: "gates in the forward-sideward scatter plots"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439742:scatter [Spatial Concept]
   748   C0439780:Forward [Spatial Concept]

Phrase: "and"

Phrase: "expressed as arbitrary units of fluorescence."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   814   C2698180:Arbitrary Fluorescence Units [Quantitative Concept]
   783   C2348686:Fluorescence Units [Quantitative Concept]
   756   C0439183:Arbitrary unit [Quantitative Concept]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0439148:Units [Quantitative Concept]
   753   C1264693:*Arbitrary [Quantitative Concept]
   753   C1519795:Units [Quantitative Concept]
   719 E C1704753:Unit [Manufactured Object]
   719 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.48: In vitro angiogenesis assay. 

Phrase: "In vitro angiogenesis assay."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1515653:In Vitro Assay [Research Activity]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.49: The angiogenic activity of EPC-conditioned media was assessed using an in vitro angiogenesis assay kit (Chemicon, Temecula, CA) and passage 2 primary human umbilical vein ECs (HUVECs). 

Phrase: "The angiogenic activity of EPC-conditioned media"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   738   C1292728:Condition activity [Functional Concept]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an in vitro angiogenesis assay kit (Chemicon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   700   C1515653:In Vitro Assay [Research Activity]

Phrase: "Temecula,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555271:Temecula [Population Group]

Phrase: "CA)"

Phrase: "and"

Phrase: "passage 2 primary human umbilical vein ECs (HUVECs)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0013806:ECS [Therapeutic or Preventive Procedure]
Processing 00000000.tx.50: Conditioned media were obtained by replacing the medium of 4-day EPC cultures with serum-free EC basal medium-2 (Clonetics, Baltimore, MD) supplemented with EGM-2 single aliquots (growth factors like vascular endothelial growth factor and basic fibroblast growth factors were omitted) and cultured for an additional 30 h. 

Phrase: "Conditioned media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "obtained by replacing"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1299987:replacing [Functional Concept]
   790   C1301820:Obtained [Functional Concept]
   756 E C1554078:Replace [Idea or Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the medium of 4-day EPC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "cultures with serum-free EC basal medium-2"
Meta Candidates (Total=25; Excluded=0; Pruned=0; Remaining=25)
   764   C0225336:Endothelial cell [Cell]
   762   C0007585:Cell Culture [Laboratory Procedure]
   762   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   762   C0596155:Basal Cell [Cell]
   762   C1183428:Free cell [Cell]
   742   C0007634:Cell [Cell]
   742   C0009458:Medium [Intellectual Product]
   742   C0010453:Culture [Idea or Concept]
   742   C0014257:Endothelial [Tissue]
   742   C0205112:Basal [Spatial Concept]
   742   C0220814:culture [Functional Concept]
   742   C0229671:Serum [Body Substance]
   742   C0332296:free [Functional Concept]
   742   C0430400:Culture [Laboratory Procedure]
   742   C0439536:Medium [Quantitative Concept]
   742   C1269647:Cell [Cell]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C1704653:Cell [Medical Device]
   742   C1705217:Medium [Substance]
   742   C1880497:Free [Qualitative Concept]
   742   C1948049:Cell [Spatial Concept]
   742   C1996904:Free [Qualitative Concept]
   742   C2242979:Culture [Laboratory Procedure]
   742   C3244283:medium [Intellectual Product]

Phrase: "(Clonetics,"

Phrase: "Baltimore,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004716:Baltimore [Geographic Area]

Phrase: "MD)"

Phrase: "supplemented with EGM-2 single aliquots"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0037179:Single [Population Group]
   753   C0087136:single [Finding]
   753   C0205171:Single [Quantitative Concept]
   719   C0242295:Supplement [Food]
   719   C1510844:Aliquot [Quantitative Concept]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "(growth factors like vascular endothelial growth factor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   835   C1256770:Vascular Endothelial Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0079280:Endothelial Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   748   C0018270:'growth' NOS [Organism Function]
   748   C0220844:growth [Physiologic Function]
   748   C1621966:Growth [Organ or Tissue Function]
   748   C2911660:Growth [Activity]
   714   C1521761:Factor [Functional Concept]
   714   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "basic fibroblast growth factors"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   983   C0380603:Fibroblast Growth Factor, Basic [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   983   C0919506:FIBROBLAST GROWTH FACTOR, BASIC [Gene or Genome]
   983   C1522505:Basic Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0016026:Fibroblast Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0016030:Fibroblast [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2911660:Growth [Activity]
   779   C1521761:Factor [Functional Concept]
   779   C2827422:Factor [Conceptual Entity]

Phrase: "were"

Phrase: "omitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitted [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "cultured for an additional 30 h."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1524062:Additional [Functional Concept]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.51: EPCs were counted, and in subsequent experiments conditioned media were diluted to correct for EPC numbers. 

Phrase: "EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: ","

Phrase: "and in subsequent experiments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0332282:Subsequent [Temporal Concept]
   770   C0681814:Experiments [Research Activity]
   770   C1515981:And [Idea or Concept]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "conditioned"
Meta Candidates (Total=9; Excluded=8; Pruned=0; Remaining=1)
  1000   C0009647:Conditioned [Mental Process]
   966 E C0012634:condition [Disease or Syndrome]
   966 E C0348080:Condition [Qualitative Concept]
   966 E C1705253:Condition [Conceptual Entity]
   928 E C0040607:Training [Educational Activity]
   928 E C0220931:Training [Educational Activity]
   928 E C0336809:Train [Manufactured Object]
   928 E C1552514:Train [Manufactured Object]
   928 E C2673163:training [Qualitative Concept]

Phrase: "media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "were"

Phrase: "diluted to correct"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C2349182:Correct [Qualitative Concept]
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]

Phrase: "for EPC numbers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.52: After 16 h, tube formation by HUVECs was measured by staining the viable cells with Calcein-AM (5 g/ml) (Molecular Probes). 

Phrase: "After 16 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "tube formation by HUVECs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C2752214:tube formation [Organ or Tissue Function]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "measured by staining"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0444706:Measured [Qualitative Concept]
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the viable cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C1441322:Viable cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "with Calcein-AM (5 g/ml) (Molecular Probes"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   818   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   795   C0182400:Probes [Medical Device]
   762 E C1704681:Probe [Gene or Genome]
   762 E C2347609:Probe [Chemical Viewed Functionally]
   762 E C3536729:Probe [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.53: Total tube area was determined using images obtained with an inverted fluorescence microscope and the Scion Imaging software (Scion Corporation, Frederick, MD) and expressed in arbitrary units. 

Phrase: "Total tube area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017446:Area [Geographic Area]
   827   C0205146:Area [Spatial Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "obtained with an inverted fluorescence microscope"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0181839:Microscope [Medical Device]
   753   C0443241:Inverted [Qualitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1706379:Microscope [Medical Device]
   719 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "the Scion Imaging software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Scion Corporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corporation [Organization]

Phrase: "Frederick,"

Phrase: "MD)"

Phrase: "and"

Phrase: "expressed in arbitrary units."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   799   C0439183:Arbitrary unit [Quantitative Concept]
   770   C0439148:Units [Quantitative Concept]
   770   C1264693:*Arbitrary [Quantitative Concept]
   770   C1519795:Units [Quantitative Concept]
   737 E C1704753:Unit [Manufactured Object]
   737 E C1880519:Unit [Quantitative Concept]
Processing 00000000.tx.54: Statistical analysis. 

Phrase: "Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.55: Statistical analysis was performed with a Students t test, and results are expressed as mean  SD. 

Phrase: "Statistical analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871424:statistical analysis [Research Activity]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed with a Students t test,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0022885:Test [Laboratory Procedure]
   753   C0038492:Students [Professional or Occupational Group]
   753   C0039593:Test [Functional Concept]
   753   C0392366:test [Intellectual Product]
   753   C0884358:Performed [Functional Concept]
   719 E C1551041:student [Idea or Concept]
   719 E C1552573:student [Intellectual Product]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as mean  SD."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.56: Linear regression analyses and Pearson correlation were used for comparison of the number of EPCs and HbA1c. 

Phrase: "Linear regression analyses"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0034980:Regression Analyses [Intellectual Product]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C0023733:Linear Regression [Quantitative Concept]
   734   C2346679:Linear Regression [Intellectual Product]

Phrase: "and"

Phrase: "Pearson correlation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709490:Pearson Correlation [Intellectual Product]
   861   C1707520:Correlation [Qualitative Concept]

Phrase: "were"

Phrase: "used for comparison of the number of EPCs"
Meta Candidates (Total=18; Excluded=6; Pruned=0; Remaining=12)
   760   C0038250:Progenitor Cells [Cell]
   757   C0225336:Endothelial Cells [Cell]
   741   C0007584:Cell Number [Laboratory Procedure]
   741   C1524063:Use of [Functional Concept]
   739   C0007634:Cells [Cell]
   739   C0014257:Endothelial [Tissue]
   739   C0237753:*Number [Quantitative Concept]
   739   C0449788:Number [Quantitative Concept]
   739   C0870134:Progenitor [Family Group]
   739   C1273517:used [Finding]
   739   C1707455:Comparison [Activity]
   739   C3282337:Cells [Cell]
   706 E C0042153:use [Functional Concept]
   706 E C0457083:Use [Functional Concept]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1947944:Use [Intellectual Product]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "HbA1c."
Processing 00000000.tx.57: Probability values of P < 0.05 were considered statistically significant.  

Phrase: "Probability values of P < 0.05"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0042295:Values [Qualitative Concept]
   719 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "statistically significant."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.58: RESULTS TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Patient characteristics. 

Phrase: "RESULTS TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Patient characteristics."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0815172:patient characteristics [Clinical Attribute]
   861   C1521970:Characteristics [Qualitative Concept]
Processing 00000000.tx.59: Subject characteristics are presented in Table 1. 

Phrase: "Subject characteristics"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0681884:subject characteristics [Research Activity]
  1000   C1519021:Subject Characteristics [Organism Attribute]
  1000   C1706465:Subject Characteristics [Idea or Concept]
   861   C1521970:Characteristics [Qualitative Concept]

Phrase: "are"

Phrase: "presented in Table 1."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C0449450:Presented [Idea or Concept]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737 E C0150312:Present [Quantitative Concept]
Processing 00000000.tx.60: The group of diabetic patients is representative of a type 1 diabetic population without macrovascular complications. 

Phrase: "The group of diabetic patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]

Phrase: "is"

Phrase: "representative of a type 1 diabetic population"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1882932:Representative [Activity]

Phrase: "without macrovascular complications."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]
Processing 00000000.tx.61: Patients widely ranged in age and HbA1c. 

Phrase: "Patients widely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "ranged in age"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0001779:Age [Organism Attribute]
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "and"

Phrase: "HbA1c."
Processing 00000000.tx.62: Background, preproliferative, and proliferative retinopathy was present in four, three, and two patients, respectively. 

Phrase: "Background,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: "preproliferative,"

Phrase: "and"

Phrase: "proliferative retinopathy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0339467:Proliferative retinopathy [Disease or Syndrome]
   861   C0035309:Retinopathy [Disease or Syndrome]
   861   C0334094:Proliferative [Pathologic Function]
   861   C1962966:Retinopathy [Finding]

Phrase: "was"

Phrase: "present in four,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]

Phrase: "three,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "and"

Phrase: "two patients,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "respectively."
Processing 00000000.tx.63: Microalbuminuria was present in 4 of 20 patients. 

Phrase: "Microalbuminuria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0730345:Microalbuminuria [Disease or Syndrome]

Phrase: "was"

Phrase: "present in 4 of 20 patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
Processing 00000000.tx.64: View this table: [in this window] [in a new window]  TABLE 1 Subject characteristics  Correlation of reduced EPC number and HbA1c in type 1 diabetic patients. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Subject characteristics  Correlation of reduced EPC number"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1707520:Correlation [Qualitative Concept]

Phrase: "and"

Phrase: "HbA1c in type 1 diabetic patients."
Processing 00000000.tx.65: Peripheral blood MNCs from type 1 diabetic patients and control subjects were cultured and differentiated. 

Phrase: "Peripheral blood MNCs from type 1 diabetic patients"

Phrase: "and"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "were"

Phrase: "cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "differentiated."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007589:Differentiated [Cell Function]
  1000   C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.66: From 4 days on, next to cell clusters, EPCs appeared with a typical spindle-shaped morphology (4). 

Phrase: "From 4 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442765:4 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "on,"

Phrase: "next to cell clusters,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1179412:cell clusters [Body Part, Organ, or Organ Component]
   779   C1555715:Cluster [Idea or Concept]
   779   C1704332:Cluster [Quantitative Concept]

Phrase: "EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "appeared with a typical spindle-shaped morphology"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0332437:Morphology [Qualitative Concept]
   748   C0332479:shaped [Spatial Concept]
   748   C0522512:shaped [Spatial Concept]
   748   C0543482:morphology [Spatial Concept]
   748   C0700329:Morphology, NOS [Finding]
   748   C0700619:Morphology [Biomedical Occupation or Discipline]
   748   C1166795:Spindle [Cell Component]
   748   C3538928:Typical [Qualitative Concept]
   714 E C0348078:shape [Qualitative Concept]
   714   C0700364:APPEAR [Qualitative Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.67: EPCs were further characterized by assessing the uptake of DiI-labeled acLDL, the binding of the lectin UEA-1, and the presence of the CD31 antigen, all three characteristic features of cells in the endothelial lineage. 

Phrase: "EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "characterized by assessing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1880022:Characterized [Activity]
   756   C1516048:Assess [Activity]

Phrase: "the uptake of DiI-labeled acLDL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243144:Uptake [Physiologic Function]
   753   C0347980:% uptake [Quantitative Concept]

Phrase: "the binding of the lectin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "UEA-1,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   937   C0617814:Ulex europaeus agglutinin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0996858:Ulex europaeus [Plant]
   840   C3486655:ULEX EUROPAEUS [Pharmacologic Substance]
   804   C0001804:Agglutinin [Immunologic Factor]
   804   C0996857:Ulex [Plant]
   804   C1524063:Using [Functional Concept]
   771 E C0042153:use [Functional Concept]
   771 E C0457083:Use [Functional Concept]
   771 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "the presence of the CD31 antigen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "all three characteristic features of cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   750   C1562749:Cell feature [Organism Attribute]
   719   C1521970:Feature [Qualitative Concept]
   719   C1706388:Feature [Conceptual Entity]
   719   C2346469:Feature [Qualitative Concept]
   719   C2348519:Feature [Qualitative Concept]

Phrase: "in the endothelial lineage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881379:Lineage [Conceptual Entity]
Processing 00000000.tx.68: At day 4, 80% of the attached cells already stained positive for all three markers. 

Phrase: "At day 4,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "80% of the attached cells already stained positive"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   767   C0439178:% positive cells [Quantitative Concept]
           % Positive
   744   C0007634:Cells [Cell]
   744   C0231441:Attached [Finding]
   744   C1446409:Positive [Qualitative Concept]
   744   C1514241:Positive [Finding]
   744   C2825490:Positive [Qualitative Concept]
   744   C2986582:Stained [Qualitative Concept]
   744   C3282337:Cells [Cell]
   711 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "for all three markers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.69: At day 7, the spindle-shaped morphology appeared more pronounced and >90% of the cells stained positive for all three markers. 

Phrase: "At day 7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "the spindle-shaped morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332437:Morphology [Qualitative Concept]
   827   C0543482:morphology [Spatial Concept]
   827   C0700329:Morphology, NOS [Finding]
   827   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "pronounced"

Phrase: "and >"

Phrase: "90% of the cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "positive for all three markers."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439178:% Positive [Quantitative Concept]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C2825490:Positive [Qualitative Concept]
Processing 00000000.tx.70: Figure 1A shows a representative picture of a dual staining of a 7-day EPC culture, and Fig. 

Phrase: "Figure 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a representative picture of a dual staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441468:picture [Manufactured Object]
   748   C0441469:Picture [Manufactured Object]

Phrase: "of a 7-day EPC culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.71: 1B represents a confocal image of a representative spindle-shaped cell in a 7-day EPC culture that shows uptake of DiI-labeled acLDL (red) and membrane staining with an anti-CD31 antibody (green). 

Phrase: "1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a confocal image of a representative spindle-shaped cell"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1704254:Image [Intellectual Product]
   742   C1704922:Image [Entity]
   742   C3542466:Image [Intellectual Product]

Phrase: "in a 7-day EPC culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C2242979:Culture [Laboratory Procedure]

Phrase: "that"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "uptake of DiI-labeled acLDL ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243144:Uptake [Physiologic Function]
   760   C0347980:% uptake [Quantitative Concept]

Phrase: "red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "membrane staining with an anti-CD31 antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0487602:Staining [Laboratory Procedure]
   748   C1704680:Staining [Finding]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.72: View larger version (31K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.73: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.74: EPC characterization. 

Phrase: "EPC characterization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880022:Characterization [Activity]
Processing 00000000.tx.75: A: Fluorescent microscopy shows a representative EPC culture containing >90% cells with a spindle-shaped morphology both staining positive for FITC-labeled Ulex europaeus agglutinin and DiI-labeled acetylated LDL. 

Phrase: "A"

Phrase: ":"

Phrase: "Fluorescent microscopy"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0026022:FLUORESCENT MICROSCOPY [Laboratory Procedure]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   789 E C0205288:Microscopic [Qualitative Concept]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a representative EPC culture"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: ">90% cells with a spindle-shaped morphology"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   774   C0162657:cells shaped [Organism Attribute]
   774   C0682540:cells spindle [Cell]
   757   C0243091:cell morphology [Qualitative Concept]
   757   C1521816:Cell morphology [Clinical Attribute]
   757   C2700385:Cell Morphology [Biomedical Occupation or Discipline]
   748   C0007634:Cells [Cell]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "both staining positive for FITC-labeled Ulex europaeus agglutinin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0439178:% Positive [Quantitative Concept]
   739   C1446409:Positive [Qualitative Concept]
   739   C1514241:Positive [Finding]
   739   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "DiI-"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "acetylated LDL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050486:acetylated LDL [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid,Pharmacologic Substance]
Processing 00000000.tx.76: B: Confocal microscopy picture showing dual staining of EPCs by CD31 antibodies and uptake DiI-labeled acLDL.  

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Confocal microscopy picture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0441468:picture [Manufactured Object]
   827   C0441469:Picture [Manufactured Object]
   734   C0242842:Microscopy, Confocal [Laboratory Procedure]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "dual staining of EPCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1704680:Staining [Finding]

Phrase: "by CD31 antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "uptake DiI-labeled acLDL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0050486:AcLDL [Amino Acid, Peptide, or Protein,Biologically Active Substance,Lipid,Pharmacologic Substance]
Processing 00000000.tx.77: After the phenotypic characterization of our EPC cultures, we assessed the number of EPCs that could be obtained from 4-day cultures derived from the peripheral blood MNC fraction of type 1 diabetic patients and age- and sex-matched control subjects. 

Phrase: "After the phenotypic characterization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880022:Characterization [Activity]

Phrase: "of our EPC cultures,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the number of EPCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "obtained from 4-day cultures"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   760   C0010453:Cultures [Idea or Concept]
   760   C0332173:/day [Temporal Concept]
   760   C0439228:day [Temporal Concept]
   760   C0439505:/day [Temporal Concept]
   760   C1301820:Obtained [Functional Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C1706701:Obtain [Activity]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "derived from the peripheral blood MNC fraction of type 1 diabetic patients"
Meta Candidates (Total=36; Excluded=2; Pruned=0; Remaining=34)
   784   C1321301:Peripheral blood mononuclear cell [Cell]
   763   C0005773:Peripheral blood cell [Cell]
           Blood cell
   763   C3642197:Fraction of 1 [Quantitative Concept]
   762   C0449475:Type of cell [Intellectual Product]
           cell type
   762   C2347293:Mononuclear Blood Cell [Cell]
   750   C0229664:peripheral blood [Body Substance]
           Blood
   750   C0441729:Type 1 [Classification]
   750   C0805525:Cell Fraction [Cell Component]
   750   C0806987:mononuclear cell [Cell]
   750   C1264633:Fraction of [Quantitative Concept]
           Fraction
   749   C0005810:blood type [Classification]
   749   C0007634:Cell Type [Cell]
           Cell
   749   C1383165:Blood Type [Clinical Attribute]
   749   C3274467:Blood Type [Diagnostic Procedure]
   735   C0005767:Blood [Tissue]
   735   C0005768:blood [Body Substance]
   735   C0030705:Patients [Patient or Disabled Group]
   735   C0205100:Peripheral [Spatial Concept]
   735   C0241863:DIABETIC [Finding]
   735   C0332307:Type [Qualitative Concept]
   735   C1269647:Cell [Cell]
   735   C1441547:Derived [Qualitative Concept]
   735   C1513475:Mononuclear [Clinical Attribute]
   735   C1547052:*Type [Quantitative Concept]
   735   C1554103:Fraction [Idea or Concept]
   735   C1704653:Cell [Medical Device]
   735   C1948049:Cell [Spatial Concept]
   735   C3245521:derived [Idea or Concept]
   732   C1550335:Patient type [Classification]
   721 E C2328697:Hemal cell [Cell]
   708 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex-matched control subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]
Processing 00000000.tx.78: We observed a significant 44% decrease in the number of EPCs obtained from 60 ml peripheral blood of the type 1 diabetic patients compared with the nondiabetic control subjects (4.3  2.3 x 106 vs. 7.8  3.3 x 106, P < 0.001, Fig. 2A). 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a significant 44% decrease in the number of EPCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0392756:Decrease [Qualitative Concept]
   738   C0547047:Decrease [Quantitative Concept]

Phrase: "obtained from 60 ml peripheral blood of the type 1 diabetic patients"
Meta Candidates (Total=18; Excluded=2; Pruned=0; Remaining=16)
   753   C0229664:peripheral blood [Body Substance]
           Blood
   753   C0441729:Type 1 [Classification]
   751   C0005810:blood type [Classification]
   751   C1383165:Blood Type [Clinical Attribute]
   751   C3274467:Blood Type [Diagnostic Procedure]
   736   C0005767:Blood [Tissue]
   736   C0005768:blood [Body Substance]
   736   C0030705:Patients [Patient or Disabled Group]
   736   C0205100:Peripheral [Spatial Concept]
   736   C0241863:DIABETIC [Finding]
   736   C0332307:Type [Qualitative Concept]
   736   C0439526:/mL [Quantitative Concept]
   736   C1301820:Obtained [Functional Concept]
   736   C1547052:*Type [Quantitative Concept]
   734   C1550335:Patient type [Classification]
   711 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   703 E C1706701:Obtain [Activity]

Phrase: "compared with the nondiabetic control subjects"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "(4.3  2.3 x 106"

Phrase: "vs. 7.8  3.3 x 106,"

Phrase: "P < 0.001,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig. 2A"

Phrase: ")."
Processing 00000000.tx.79: Moreover, linear regression analyses revealed an inverse relationship between the number of EPCs and the HbA1c in the patients (R = -0.68, P = 0.01, Fig. 2B). 

Phrase: "Moreover,"

Phrase: "linear regression analyses"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0034980:Regression Analyses [Intellectual Product]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C0023733:Linear Regression [Quantitative Concept]
   734   C2346679:Linear Regression [Intellectual Product]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "an inverse relationship between the number of EPCs"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0439849:Relationship [Qualitative Concept]
   739   C1705630:Relationship [Idea or Concept]
   739   C1706279:Relationship [Idea or Concept]
   739   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "the HbA1c in the patients"

Phrase: "(R = -0.68,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205090:R- [Spatial Concept]
   827   C0450387:68 [Intellectual Product]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "P = 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.80: View larger version (16K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.81: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.82: MNCs were isolated out of 60 ml peripheral blood from 20 control subjects and 20 type 1 diabetic patients. 

Phrase: "MNCs"

Phrase: "were"

Phrase: "isolated out of 60 ml peripheral blood"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0229664:peripheral blood [Body Substance]
           Blood
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0205100:Peripheral [Spatial Concept]
   748   C0205409:Isolated [Functional Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C0439787:Out [Spatial Concept]
   748   C0849355:Out [Qualitative Concept]
   748   C1548221:Isolated [Idea or Concept]
   737 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "from 20 control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
   793   C0681850:Subject [Group]
   793   C1550501:{Subject} [Idea or Concept]
   793   C1706203:Subject [Idea or Concept]
   793   C2349001:Subject [Human]
   793   C2697811:Subject [Functional Concept]

Phrase: "and"

Phrase: "20 type 1 diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.83: MNCs were plated on gelatin-coated dishes, and EPCs were cultured for 4 days. 

Phrase: "MNCs"

Phrase: "were"

Phrase: "plated on gelatin-coated dishes,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0017237:Gelatin [Amino Acid, Peptide, or Protein,Biomedical or Dental Material,Pharmacologic Substance]
   760   C1145617:Gelatin [Food]
   760   C1522408:Coated [Qualitative Concept]
   726   C0005971:Plate [Medical Device]
   726   C0020498:DISH [Disease or Syndrome]
   726 E C0453946:Coat [Manufactured Object]
   726   C1139930:plate [Medical Device]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]
   726   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 4 days."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0439228:days [Temporal Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737 E C0332173:/day [Temporal Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C0439505:/day [Temporal Concept]
   737   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.84: A: The total EPC numbers were counted and a 44% reduction was seen in the type 1 diabetic patients compared with the healthy control subjects. 

Phrase: "A"

Phrase: ":"

Phrase: "The total EPC numbers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "a 44% reduction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0301630:Reduction [Natural Phenomenon or Process]
   861   C0392756:Reduction [Qualitative Concept]
   861   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "seen in the type 1 diabetic patients"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   778   C0441729:Type 1 [Classification]
   757   C1550335:Patient type [Classification]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0205397:Seen [Qualitative Concept]
   748   C0241863:DIABETIC [Finding]
   748   C0332307:Type [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "compared with the healthy control subjects."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C2986479:Healthy Control [Qualitative Concept]
   783   C1708335:HEALTHY SUBJECTS [Population Group]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]
Processing 00000000.tx.85: B: This reduction in EPC numbers inversely correlated with glycemic control assessed by HbA1c.  

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "This reduction in EPC numbers inversely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "correlated with glycemic control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707520:Correlated [Qualitative Concept]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "assessed by HbA1c."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1516048:Assessed [Activity]
Processing 00000000.tx.86: No evidence for increased apoptosis in cultured EPCs from type 1 diabetic patients. 

Phrase: "No evidence for increased apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "in cultured EPCs"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   902   C0007600:cultured cells [Cell]
   902   C0007635:Cultured Cells [Cell]
   902   C3282338:Cells, Cultured [Cell]
   875   C0225336:Endothelial Cells [Cell]
   861   C0038250:Progenitor Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C0870134:Progenitor [Family Group]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "from type 1 diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.87: To evaluate if the reduction in the number of EPCs was due to apoptosis, we analyzed the binding of Annexin V to phosphatidylserine in both EPCs cultured for 4 days and the MNC fraction they originated from. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "if"

Phrase: "the reduction in the number of EPCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was due to apoptosis,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0043194:WAS [Disease or Syndrome]
   770   C0162638:Apoptosis [Cell Function]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]
   770   C3146286:Due [Idea or Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the binding of Annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to phosphatidylserine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031623:phosphatidylserine [Lipid]
  1000   C0301704:Phosphatidyl serine [Lipid]

Phrase: "in both EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "cultured for 4 days"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0439228:days [Temporal Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737 E C0332173:/day [Temporal Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C0439505:/day [Temporal Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "the MNC fraction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0805525:Cell Fraction [Cell Component]
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C0806987:mononuclear cell [Cell]

Phrase: "they"

Phrase: "originated from."
Processing 00000000.tx.88: The display of phosphatidylserine in the outer leaflet of the plasma membrane of cells is considered an early marker of apoptosis. 

Phrase: "The display of phosphatidylserine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705417:Display [Manufactured Object]

Phrase: "in the outer leaflet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708664:Leaflet [Manufactured Object]
   861   C3273178:Leaflet [Intellectual Product]

Phrase: "of the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "of cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "an early marker of apoptosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.89: Quantitative analyses of data obtained by flow cytometry revealed no significant difference in the mean levels of Annexin V binding to EPCs cultured from patients or control subjects when gated for viable cells (22.3  10.7 and 20.4  9.2, respectively, P = 0.54), suggesting no increase in early apoptosis in these cells. 

Phrase: "Quantitative analyses of data"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   856   C0681919:quantitative data analysis [Research Activity]
   819   C0010992:Data Analyses [Occupational Activity]
   737   C0002778:Analysis [Laboratory Procedure]
   737   C0936012:Analysis [Research Activity]
   737   C1524024:analysis [Functional Concept]

Phrase: "obtained by flow cytometry"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0016263:Flow Cytometry [Laboratory Procedure]
   770   C0806140:Flow [Natural Phenomenon or Process]
   770   C0814048:Cytometry [Laboratory Procedure]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "no significant difference in the mean levels of Annexin V binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1705241:*Difference [Quantitative Concept]
   738   C1705242:Difference [Qualitative Concept]

Phrase: "to EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "cultured from patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0030705:Patients [Patient or Disabled Group]
   756   C0010453:Culture [Idea or Concept]
   756   C0220814:culture [Functional Concept]
   756   C0430400:Culture [Laboratory Procedure]
   756   C2242979:Culture [Laboratory Procedure]

Phrase: "or"

Phrase: "control subjects"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0681850:Subject [Group]
   827   C1550501:{Subject} [Idea or Concept]
   827   C1706203:Subject [Idea or Concept]
   827   C2349001:Subject [Human]
   827   C2697811:Subject [Functional Concept]

Phrase: "when"

Phrase: "gated for viable cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C1441322:Viable cells [Cell]
   770   C0007634:Cells [Cell]
   770   C0443348:Viable [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "(22.3  10.7"

Phrase: "and"

Phrase: "20.4  9.2,"

Phrase: "respectively,"

Phrase: "P = 0.54"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "no increase in early apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "in these cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.90: Likewise, in fresh MNC fractions, which were the source of our EPC cultures, we also did not observe a significant increase in the mean levels of Annexin V binding of the total MNC fraction in the patient group compared with that of the control subjects (370.9  78.5 vs. 304.7  139.5, P = 0.17). 

Phrase: "Likewise,"

Phrase: "in fresh MNC fractions,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0805525:Cell fractions [Cell Component]
   812   C1264633:Fractions [Quantitative Concept]
   779 E C1554103:Fraction [Idea or Concept]

Phrase: "which"

Phrase: "were"

Phrase: "the source of our EPC cultures,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449416:Source [Finding]
   753   C1705919:Source [Idea or Concept]

Phrase: "we also"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "a significant increase in the mean levels of Annexin V binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0442805:Increase [Functional Concept]

Phrase: "of the total MNC fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0805525:Cell Fraction [Cell Component]
   812   C1264633:Fraction [Quantitative Concept]
   812   C1554103:Fraction [Idea or Concept]

Phrase: "in the patient group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "compared with that of the control subjects"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1707455:Compared [Activity]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]
   714   C0681850:Subject [Group]
   714   C1550501:{Subject} [Idea or Concept]
   714   C1706203:Subject [Idea or Concept]
   714   C2349001:Subject [Human]
   714   C2697811:Subject [Functional Concept]

Phrase: "(370.9  78.5"

Phrase: "vs. 304.7  139.5,"

Phrase: "P = 0.17"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.91: EPCs from patients with type 1 diabetes are impaired in their potential to augment angiogenesis in vitro. 

Phrase: "EPCs from patients"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0038250:Progenitor Cells [Cell]
   797   C0225336:Endothelial Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0014257:Endothelial [Tissue]
   760   C0870134:Progenitor [Family Group]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "with type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "are"

Phrase: "impaired in their potential to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0221099:Impaired [Functional Concept]
   760   C0684336:Impaired [Pathologic Function]
   760   C3245505:Potential [Qualitative Concept]

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "angiogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.92: EPCs are thought to augment neovascularization not only by integration of these cells into newly developing capillaries, but also in a paracrine fashion through the secretion of angiogenic growth factors (5). 

Phrase: "EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "neovascularization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027686:Neovascularisation [Pathologic Function]

Phrase: "not only by integration of these cells"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   748   C0007634:Cells [Cell]
   748   C0205171:Only [Quantitative Concept]
   748   C1158478:Integration [Genetic Function]
   748   C1518422:Not [Functional Concept]
   748   C1705422:Integration [Machine Activity]
   748   C1720467:Only [Intellectual Product]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "into newly developing capillaries,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0006901:Capillaries [Body Part, Organ, or Organ Component]
   827   C0935624:Capillaries [Body Part, Organ, or Organ Component]
   793 E C1280521:Capillary [Body Part, Organ, or Organ Component]

Phrase: "but"

Phrase: "also in a paracrine fashion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597170:paracrine [Physiologic Function]

Phrase: "through the secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]

Phrase: "of angiogenic growth factors"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896   C0002976:Angiogenic Factor [Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.93: To investigate whether this paracrine function is affected in type 1 diabetes, we determined the angiogenic potential of EPC (day 4)-conditioned medium in an in vitro angiogenesis model. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "this paracrine function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "affected in type 1 diabetes,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   862   C0011854:Type 1 diabetes [Disease or Syndrome]
   806   C0441729:Type 1 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C0392760:Affected [Functional Concept]
   760   C1314939:Affected [Functional Concept]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0001721:Affect [Mental Process]

Phrase: "we"

Phrase: "determined"

Phrase: "the angiogenic potential of EPC (day 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3245505:Potential [Qualitative Concept]

Phrase: ")-"

Phrase: "conditioned medium in an in vitro angiogenesis model."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   744   C0009458:Medium [Intellectual Product]
   744   C0439536:Medium [Quantitative Concept]
   744   C1705217:Medium [Substance]
   744   C3244283:medium [Intellectual Product]
Processing 00000000.tx.94: In this angiogenesis model, the degree of tube formation of mature ECs on a solid gel of matrix proteins can be evaluated. 

Phrase: "In this angiogenesis model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "the degree of tube formation of mature ECs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0441889:Degree [Qualitative Concept]
   744   C0449286:Degree [Quantitative Concept]
   744   C0542560:Degree [Intellectual Product]
   744   C1561545:degree [Quantitative Concept]
   744   C2348088:Degree [Quantitative Concept]

Phrase: "on a solid gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "of matrix proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1704640:Matrix [Spatial Concept]
   861   C1706515:Matrix [Body Substance]

Phrase: "can"

Phrase: "be"

Phrase: "evaluated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]
Processing 00000000.tx.95: As tube formation in this assay is dependent on the presence of angiogenic stimuli we assessed the angiogenic capacity of cultured EPC. 

Phrase: "As tube formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2752214:tube formation [Organ or Tissue Function]
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "in this assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "is"

Phrase: "dependent on the presence of angiogenic stimuli"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C3244310:dependent [Functional Concept]

Phrase: "we"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "the angiogenic capacity of cultured EPC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516240:Capacity [Quantitative Concept]
Processing 00000000.tx.96: HUVECs were seeded on extracellular matrix and subjected overnight to conditioned medium of diabetic EPCs (n = 10) or of EPCs from age-matched control subjects (n = 10). 

Phrase: "HUVECs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013806:ECS [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "seeded on extracellular matrix"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0015350:Extracellular Matrix [Tissue]
   770   C0521119:Extracellular [Cell Component]
   770   C1704640:Matrix [Spatial Concept]
   770   C1706515:Matrix [Body Substance]
   737   C0036563:Seed [Plant]
   737   C1705192:Seed [Laboratory Procedure]
   737   C1882540:{Seed} [Quantitative Concept]
   737   C2346495:Seed [Conceptual Entity]

Phrase: "and"

Phrase: "subjected"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0681850:Subject [Group]
   966   C1550501:{Subject} [Idea or Concept]
   966   C1706203:Subject [Idea or Concept]
   966   C2349001:Subject [Human]
   966   C2697811:Subject [Functional Concept]

Phrase: "overnight to conditioned medium of diabetic EPCs"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   764   C0038250:Progenitor Cells [Cell]
   764   C0162518:Conditioned Medium [Indicator, Reagent, or Diagnostic Aid]
   762   C0225336:Endothelial Cells [Cell]
   742   C0007634:Cells [Cell]
   742   C0009458:Medium [Intellectual Product]
   742   C0009647:Conditioned [Mental Process]
   742   C0014257:Endothelial [Tissue]
   742   C0241863:DIABETIC [Finding]
   742   C0439536:Medium [Quantitative Concept]
   742   C0439583:Overnight [Temporal Concept]
   742   C0870134:Progenitor [Family Group]
   742   C1705217:Medium [Substance]
   742   C3244283:medium [Intellectual Product]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "(n = 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "or of EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0038250:Progenitor Cells [Cell]
   797   C0225336:Endothelial Cells [Cell]
   760   C0007634:Cells [Cell]
   760   C0014257:Endothelial [Tissue]
   760   C0870134:Progenitor [Family Group]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "from age-matched control subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]

Phrase: "(n = 10"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.97: Conditioned media of healthy control subjects markedly stimulated tube formation when compared with nonconditioned media (EGM-/-), demonstrating that EPCs can facilitate angiogenesis in a paracrine fashion (Fig. 3). 

Phrase: "Conditioned media of healthy control"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "markedly stimulated tube formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C2752214:tube formation [Organ or Tissue Function]
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]

Phrase: "when"

Phrase: "compared with nonconditioned media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1707455:Compared [Activity]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "(EGM-/-"

Phrase: ")"

Phrase: ","

Phrase: "demonstrating"

Phrase: "that EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "facilitate"

Phrase: "angiogenesis in a paracrine fashion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0302600:Angiogenesis [Organ or Tissue Function]
   760   C1519670:angiogenesis [Neoplastic Process]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.98: In contrast, the conditioned media of the patient EPCs significantly reduced tube formation when compared with nonconditioned media, suggesting that cultured EPCs from type 1 diabetic patients can secrete factors that impair angiogenesis in vitro. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the conditioned media of the patient EPCs significantly reduced tube formation"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   750   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   735   C0009458:Media [Intellectual Product]
   735   C0162867:Media [Tissue]
   735   C1254021:Media [Tissue]
   702 E C0439536:Medium [Quantitative Concept]
   702 E C1705217:Medium [Substance]
   702 E C3244283:medium [Intellectual Product]

Phrase: "when"

Phrase: "compared with nonconditioned media,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C1254021:Media [Tissue]
   770   C1707455:Compared [Activity]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C1705217:Medium [Substance]
   737 E C3244283:medium [Intellectual Product]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that cultured EPCs from type 1 diabetic patients"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   760   C0038250:Progenitor Cells [Cell]
   757   C0007600:cultured cells [Cell]
   757   C0007635:Cultured Cells [Cell]
   757   C0225336:Endothelial Cells [Cell]
   757   C0449475:cells type [Intellectual Product]
   757   C3282338:Cells, Cultured [Cell]
   741 E C0007634:Cell Type [Cell]
           Cells
   739   C0014257:Endothelial [Tissue]
   739   C0870134:Progenitor [Family Group]
   739   C3282337:Cells [Cell]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "can"

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "impair"

Phrase: "angiogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.99: View larger version (17K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.100: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.101: Angiogenic capacity of conditioned media of EPCs in an in vitro angiogenesis assay. 

Phrase: "Angiogenic capacity of conditioned media of EPCs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1516240:Capacity [Quantitative Concept]

Phrase: "in an in vitro angiogenesis assay."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C1515653:In Vitro Assay [Research Activity]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.102: HUVECs were plated on extracellular matrix and subjected to EPC-conditioned media. 

Phrase: "HUVECs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0013806:ECS [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "plated on extracellular matrix"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0015350:Extracellular Matrix [Tissue]
   770   C0521119:Extracellular [Cell Component]
   770   C1704640:Matrix [Spatial Concept]
   770   C1706515:Matrix [Body Substance]
   737   C0005971:Plate [Medical Device]
   737   C1139930:plate [Medical Device]
   737   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "subjected to EPC-conditioned media."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Media [Intellectual Product]
   760   C0009647:Conditioned [Mental Process]
   760   C0162867:Media [Tissue]
   760   C0169014:EPC [Organophosphorus Compound,Pharmacologic Substance]
   760   C1254021:Media [Tissue]
   726 E C0439536:Medium [Quantitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726 E C1705217:Medium [Substance]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
   726 E C3244283:medium [Intellectual Product]
Processing 00000000.tx.103: Tubule networks were formed overnight and structures were visualized with Calcein-AM staining. 

Phrase: "Tubule networks"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1882071:networks [Conceptual Entity]
   827 E C1513822:Network [Professional or Occupational Group]
   827 E C1705739:Network [Manufactured Object]

Phrase: "were"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: "overnight"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "and"

Phrase: "structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "visualized with Calcein-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0060549:Calcein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C0234621:Visualized [Functional Concept]

Phrase: "AM"

Phrase: "staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
Processing 00000000.tx.104: Quantitative analyses of tube formation were performed using an imaging program. 

Phrase: "Quantitative analyses of tube formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an imaging program."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1709697:Program [Conceptual Entity]
   861   C2728259:Program [Pharmacologic Substance]
   861   C3484370:Program [Functional Concept]
Processing 00000000.tx.105: A: A significant inhibition of tube formation of patient EPC conditioned media is shown. 

Phrase: "A"

Phrase: ":"

Phrase: "A significant inhibition of tube formation of patient EPC conditioned media"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0234408:Conditioned inhibition [Mental Process]
   738   C0021467:Inhibition [Mental Process]
   738   C0021469:Inhibition [Molecular Function]
   738   C1628982:% inhibition [Quantitative Concept]
   738   C3463820:Inhibition [Activity]

Phrase: "is"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.106: B: Representative pictures of the stained tubule networks formed after incubation of HUVECs with the conditioned media of EPCs derived from thee different patients and their age- and sex-matched control subjects.   

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Representative pictures of the stained tubule networks"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0441469:pictures [Manufactured Object]
   714 E C0441468:picture [Manufactured Object]

Phrase: "formed after incubation of HUVECs"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   770   C0041637:Umbilical vein [Embryonic Structure]
   770   C0221313:Umbilical vein [Embryonic Structure]
   770   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   744   C0013806:ECS [Therapeutic or Preventive Procedure]
   744   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   744   C0042449:Vein [Body Part, Organ, or Organ Component]
   744   C0086418:Human [Human]
   744   C0205431:Formed [Functional Concept]
   744   C1278960:Vein [Body Part, Organ, or Organ Component]
   711 E C0348078:Form [Qualitative Concept]
   711 E C0376315:Form [Manufactured Object]
   711 E C1522492:Form [Functional Concept]

Phrase: "with the conditioned media"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0162518:Conditioned Media [Indicator, Reagent, or Diagnostic Aid]
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C1254021:Media [Tissue]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "of EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "derived from thee different patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C1441547:Derived [Qualitative Concept]
   760   C1705242:Different [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "their age-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "sex-matched control subjects."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0681850:Subject [Group]
   779   C1550501:{Subject} [Idea or Concept]
   779   C1706203:Subject [Idea or Concept]
   779   C2349001:Subject [Human]
   779   C2697811:Subject [Functional Concept]
Processing 00000000.tx.107: DISCUSSION TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Our data support the hypothesis that EPCs are dysfunctional in patients with type 1 diabetes. 

Phrase: "DISCUSSION TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0035171:Research Design [Research Activity]
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
   804   C1707689:Design [Activity]
   804   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "dysfunctional in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   718   C0031847:dysfunction [Functional Concept]
   718   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "with type 1 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.108: First, a reduced number of EPCs could be cultured from the MNC fraction of type 1 diabetic patients when compared with healthy control subjects. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "a reduced number of EPCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "cultured from the MNC fraction of type 1 diabetic patients"
Meta Candidates (Total=26; Excluded=1; Pruned=0; Remaining=25)
   772   C3642197:Fraction of 1 [Quantitative Concept]
   770   C0449475:Type of cell [Intellectual Product]
           cell type
   756   C0441729:Type 1 [Classification]
   756   C0805525:Cell Fraction [Cell Component]
   756   C0806987:mononuclear cell [Cell]
   756   C1264633:Fraction of [Quantitative Concept]
           Fraction
   754   C0007634:Cell Type [Cell]
           Cell
   754   C0007635:cultured cell [Cell]
   738   C0030705:Patients [Patient or Disabled Group]
   738   C0241863:DIABETIC [Finding]
   738   C0332307:Type [Qualitative Concept]
   738   C1269647:Cell [Cell]
   738   C1513475:Mononuclear [Clinical Attribute]
   738   C1547052:*Type [Quantitative Concept]
   738   C1554103:Fraction [Idea or Concept]
   738   C1704653:Cell [Medical Device]
   738   C1948049:Cell [Spatial Concept]
   737 E C0007585:Cell Culture [Laboratory Procedure]
   737   C1550335:Patient type [Classification]
   704   C0010453:Culture [Idea or Concept]
   704   C0220814:culture [Functional Concept]
   704   C0430400:Culture [Laboratory Procedure]
   704   C2242979:Culture [Laboratory Procedure]

Phrase: "when"

Phrase: "compared with healthy control subjects."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C2986479:Healthy Control [Qualitative Concept]
   797   C1708335:HEALTHY SUBJECTS [Population Group]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.109: A reduction of the number of EPCs in patients with risk factors for coronary artery disease has also been reported by others (68). 

Phrase: "A reduction of the number of EPCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0035648:risk factors [Quantitative Concept]
  1000   C1553898:risk factors [Idea or Concept]
   861   C0035647:Risk [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "for coronary artery disease"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0010054:coronary artery disease [Disease or Syndrome]
  1000   C0010068:Coronary (artery) disease [Disease or Syndrome]
           Coronary Disease
  1000   C1956346:Coronary Artery Disease [Disease or Syndrome]
   901   C0205042:Coronary artery [Body Part, Organ, or Organ Component]
   901   C0852949:artery disease [Disease or Syndrome]
   901   C1269008:Coronary artery [Body Part, Organ, or Organ Component]
   827   C0003842:Artery [Body Part, Organ, or Organ Component]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0018787:coronary [Body Part, Organ, or Organ Component]
   827   C0226004:artery [Body System]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C0221464:Arterial [Spatial Concept]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported by others"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C1709908:Reported By [Group]
   790   C0684224:Reported [Intellectual Product]
   790   C0700287:Reported [Health Care Activity]
   790   C1955473:Others [Finding]
   790   C3496591:Reported [Clinical Attribute]
   756 E C3273238:Report [Intellectual Product]

Phrase: "(68"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450387:68 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.110: Our data are consistent with a previous report by Schatteman et al. 

Phrase: "Our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with a previous report"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "by Schatteman et al."
Processing 00000000.tx.111: (7), who showed that CD34+ cells derived from type 1 diabetic patients produced less differentiated ECs than their non-diabetic derived counterparts. 

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that CD34+ cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0882849:cd34 cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "derived from type 1 diabetic patients"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0441729:Type 1 [Classification]
   767   C1550335:Patient type [Classification]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C1441547:Derived [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   753   C3245521:derived [Idea or Concept]

Phrase: "produced"

Phrase: "less differentiated ECs than their non-diabetic derived counterparts."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0013806:ECS [Therapeutic or Preventive Procedure]
Processing 00000000.tx.112: Here, we have extended their observation by showing that in type 1 diabetes, EPC numbers inversely correlate with HbA1c levels, demonstrating that the degree of glycemic dysregulation directly affects EPC proliferation or differentiation. 

Phrase: "Here,"

Phrase: "we"

Phrase: "have"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "their observation by showing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0302523:Observation [Research Activity]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]

Phrase: "that in type 1 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0011854:Type 1 diabetes [Disease or Syndrome]
   806   C0441729:Type 1 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "EPC numbers inversely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]

Phrase: "correlate with HbA1c levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0441889:Levels [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "demonstrating"

Phrase: "that"

Phrase: "the degree of glycemic dysregulation directly"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]

Phrase: "affects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "EPC proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "or"

Phrase: "differentiation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.113: As the number of circulating leukocytes is tightly regulated by the balance between proliferation and apoptosis (11), and as increased apoptosis has been associated with the adverse metabolic state and oxidative stress in diabetes (12), we hypothesized that increased apoptosis could explain the reduced EPC numbers. 

Phrase: "As the number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of circulating leukocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023516:Leukocytes [Cell]

Phrase: "is"

Phrase: "tightly"

Phrase: "regulated by the balance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0014653:Balance [Organism Function]
   770   C0205415:Balance [Functional Concept]
   770   C0560184:Balance [Finding]
   770   C0851285:Regulated [Governmental or Regulatory Activity]

Phrase: "between proliferation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0334094:Proliferation [Pathologic Function]
  1000   C1514485:Proliferation [Functional Concept]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "and as increased apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0162638:Apoptosis [Cell Function]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "associated with the adverse metabolic state"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C0311400:Metabolic [Functional Concept]
   753   C1301808:State [Geographic Area]
   753   C1442792:State [Functional Concept]
   753   C1524026:Metabolic [Cell Function]
   753   C2707259:Metabolic [Clinical Attribute]
   753   C3148680:State [Geographic Area]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "oxidative stress in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   770   C0038435:Stress [Finding]
   770   C0311404:Oxidative [Functional Concept]

Phrase: "(12"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that increased apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "could"

Phrase: "explain"

Phrase: "the reduced EPC numbers."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0237753:*Number [Quantitative Concept]
   827   C0449788:Number [Quantitative Concept]
Processing 00000000.tx.114: When we analyzed early apoptosis in EPCs cultured for 4 days or in the freshly isolated MNC fraction they originate from, no significant difference in the mean levels of Annexin V binding was detected in the type 1 diabetic patient group compared with the control group. 

Phrase: "When"

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "early apoptosis in EPCs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   803   C3156636:endothelial cell apoptosis [Cell Function]
   753   C0162638:Apoptosis [Cell Function]

Phrase: "cultured for 4 days"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0439228:days [Temporal Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737 E C0332173:/day [Temporal Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C0439505:/day [Temporal Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "or in the freshly"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "MNC fraction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0805525:Cell Fraction [Cell Component]
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C0806987:mononuclear cell [Cell]

Phrase: "they"

Phrase: "originate from,"

Phrase: "no significant difference in the mean levels of Annexin V binding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1705241:*Difference [Quantitative Concept]
   738   C1705242:Difference [Qualitative Concept]

Phrase: "was"

Phrase: "detected in the type 1 diabetic patient group"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0441729:Type 1 [Classification]
   767   C0441861:Group 1 [Intellectual Product]
   767   C1550335:Patient type [Classification]
   744   C0030705:*^patient [Patient or Disabled Group]
   744   C0241863:DIABETIC [Finding]
   744   C0332307:Type [Qualitative Concept]
   744   C0441833:Group [Idea or Concept]
   744   C0442726:Detected [Finding]
   744   C0687744:group [Population Group]
   744   C1257890:Group [Population Group]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1547052:*Type [Quantitative Concept]
   744   C1552516:Group [Health Care Related Organization]
   744   C1705428:Group [Conceptual Entity]
   744   C1705429:Group [Population Group]

Phrase: "compared with the control group."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0009932:Control Group [Group]
   760   C0243148:control [Qualitative Concept]
   760   C0441833:Group [Idea or Concept]
   760   C0687744:group [Population Group]
   760   C1257890:Group [Population Group]
   760   C1550141:Control [Substance]
   760   C1552516:Group [Health Care Related Organization]
   760   C1705428:Group [Conceptual Entity]
   760   C1705429:Group [Population Group]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.115: These data suggest that increased apoptosis is unlikely to be involved in the reduction of the number of EPCs in type 1 diabetic patients. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that increased apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "be"

Phrase: "involved in the reduction of the number of EPCs"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   756   C0038250:Progenitor Cells [Cell]
   754   C0225336:Endothelial Cells [Cell]
   738   C0007634:Cells [Cell]
   738   C0014257:Endothelial [Tissue]
   738   C0237753:*Number [Quantitative Concept]
   738   C0301630:Reduction [Natural Phenomenon or Process]
   738   C0392756:Reduction [Qualitative Concept]
   738   C0441610:Reduction [Therapeutic or Preventive Procedure]
   738   C0449788:Number [Quantitative Concept]
   738   C0870134:Progenitor [Family Group]
   738   C1314939:Involved [Functional Concept]
   738   C3282337:Cells [Cell]
   737   C0007584:Cell Number [Laboratory Procedure]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "in type 1 diabetic patients."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]
Processing 00000000.tx.116: An alternative explanation for the lower EPC counts in this study could be that the EPC precursors in the MNC fraction have an impaired capacity to adhere and/or differentiate in our culture conditions. 

Phrase: "An alternative explanation for the lower EPC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681841:Explanation [Intellectual Product]

Phrase: "counts in this study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0439157:counts [Quantitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C0750480:Count [Activity]
   770   C1705566:Count [Quantitative Concept]
   770   C2603343:Study [Research Activity]

Phrase: "could"

Phrase: "be"

Phrase: "that"

Phrase: "the EPC precursors in the MNC fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   750   C0018956:precursor cell [Cell]
   711   C1709634:Precursor [Idea or Concept]

Phrase: "have"

Phrase: "an impaired capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "adhere"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231441:Adhere [Finding]

Phrase: "and/or"

Phrase: "differentiate in our culture conditions."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0010453:Culture [Idea or Concept]
   760   C0205615:differentiate [Qualitative Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C2242979:Culture [Laboratory Procedure]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.117: This would represent yet another level of EPC dysfunction that is currently under investigation. 

Phrase: "This"

Phrase: "would"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "yet"

Phrase: "another level of EPC dysfunction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0441889:Level [Qualitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "is"

Phrase: "currently under investigation."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0521116:Currently [Temporal Concept]
   790   C1261322:Investigation [Health Care Activity]
   790   C1552578:investigation [Idea or Concept]
   718 E C1517586:Investigational [Qualitative Concept]
   718 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.118: Irrespective of the underlying mechanism, a reduced number of EPCs is likely to impact on vascular integrity as it was recently reported that, in healthy men, the number of EPCs serve as a surrogate marker for vascular function and cumulative cardiovascular risk (9). 

Phrase: "Irrespective of the underlying mechanism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "a reduced number of EPCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   757   C0007584:Cell Number [Laboratory Procedure]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]

Phrase: "is"

Phrase: "likely to impact"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332148:Likely [Qualitative Concept]
   790   C0750492:Likely [Idea or Concept]
   790   C1825598:IMPACT [Gene or Genome]

Phrase: "on vascular integrity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205266:integrity [Qualitative Concept]
   861   C0872403:integrity [Individual Behavior]
   861   C1947912:Integrity [Qualitative Concept]

Phrase: "as"

Phrase: "it"

Phrase: "was"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that,"

Phrase: "in healthy men,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0025266:Men [Population Group]
   827 E C0024554:MAN [Finding]
   827 E C0086418:Man [Human]

Phrase: "the number of EPCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "serve as a surrogate marker"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0086589:Surrogate Marker [Qualitative Concept]
   760   C0005516:Marker [Clinical Attribute]

Phrase: "for vascular function"
Meta Candidates (Total=18; Excluded=10; Pruned=0; Remaining=8)
  1000   C0232337:Vascular function [Clinical Attribute]
   950 E C0005811:blood function [Organ or Tissue Function]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1558950:VASCULAR [Finding]
   861   C1705273:Function [Intellectual Product]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "and"

Phrase: "cumulative cardiovascular risk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0007226:Cardiovascular [Body System]
   827   C0035647:Risk [Qualitative Concept]

Phrase: "(9"

Phrase: ")."
Processing 00000000.tx.119: Having established that the number of EPCs is reduced in type 1 diabetes, we determined if the function of the remaining cells was altered compared with the control subjects. 

Phrase: "Having"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "that"

Phrase: "the number of EPCs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "is"

Phrase: "reduced in type 1 diabetes,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0011854:Type 1 diabetes [Disease or Syndrome]
   806   C0441729:Type 1 [Classification]
   797   C1320657:Diabetes type [Finding]
   760   C0011847:Diabetes [Disease or Syndrome]
   760   C0011849:Diabetes [Disease or Syndrome]
   760   C0332307:Type [Qualitative Concept]
   760   C0392756:Reduced [Qualitative Concept]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "we"

Phrase: "determined"

Phrase: "if"

Phrase: "the function of the remaining cells"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0007613:cells function [Cell Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "was"

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "compared with the control subjects."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]
Processing 00000000.tx.120: So far, only few studies addressed the subject of EPC dysfunction. 

Phrase: "So"

Phrase: "far,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205108:far [Spatial Concept]

Phrase: "only few studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: "the subject of EPC dysfunction."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0681850:Subject [Group]
   760   C1550501:{Subject} [Idea or Concept]
   760   C1706203:Subject [Idea or Concept]
   760   C2349001:Subject [Human]
   760   C2697811:Subject [Functional Concept]
Processing 00000000.tx.121: It was reported that EPCs isolated from patients with coronary artery disease displayed an impaired migratory response (6) and that, in type 2 diabetes, EPC adhesion to stimulated ECs is impaired (8). 

Phrase: "It"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "isolated from patients"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "with coronary artery disease"
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0010054:coronary artery disease [Disease or Syndrome]
  1000   C0010068:Coronary (artery) disease [Disease or Syndrome]
           Coronary Disease
  1000   C1956346:Coronary Artery Disease [Disease or Syndrome]
   901   C0205042:Coronary artery [Body Part, Organ, or Organ Component]
   901   C0852949:artery disease [Disease or Syndrome]
   901   C1269008:Coronary artery [Body Part, Organ, or Organ Component]
   827   C0003842:Artery [Body Part, Organ, or Organ Component]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0018787:coronary [Body Part, Organ, or Organ Component]
   827   C0226004:artery [Body System]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C0221464:Arterial [Spatial Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "an impaired migratory response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0871261:Response [Organism Attribute]
   827   C1704632:Response [Finding]
   827   C1706817:Response [Intellectual Product]
   827   C2911692:Response [Mental Process]

Phrase: "(6"

Phrase: ")"

Phrase: "and"

Phrase: "that,"

Phrase: "in type 2 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011860:Type 2 Diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441730:Type 2 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "EPC adhesion to stimulated ECs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0001511:Adhesion [Pathologic Function]
   760   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.122: Although EPCs enhance new vessel formation, these cells do not form the entire vessel de novo and the process always includes mature ECs (13). 

Phrase: "Although"

Phrase: "EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "new vessel formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "these cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "the entire vessel"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0005847:Vessel [Body Part, Organ, or Organ Component]
   861   C1511228:Vessel [Tissue]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "de novo"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1515568:de novo [Idea or Concept]
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "and"

Phrase: "the process always"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "mature ECs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013806:ECS [Therapeutic or Preventive Procedure]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.123: Recently, it has been suggested that a major function of EPCs could be the secretion of angiogenic factors to activate resident mature ECs (14). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a major function of EPCs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0007613:cells function [Cell Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "the secretion of angiogenic factors to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "resident mature ECs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013806:ECS [Therapeutic or Preventive Procedure]

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.124: Here we show that the angiogenic capacity of conditioned media from patient-derived EPCs is not only reduced, but it also may contain an inhibitor for in vitro tube formation of ECs. 

Phrase: "Here"

Phrase: "we"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the angiogenic capacity of conditioned media"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1516240:Capacity [Quantitative Concept]

Phrase: "from patient-derived EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   853   C0225336:Endothelial Cells [Cell]
   840   C0038250:Progenitor Cells [Cell]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0870134:Progenitor [Family Group]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: ","

Phrase: "but"

Phrase: "it also"

Phrase: "may"

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "an inhibitor for in vitro tube formation of ECs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.125: Furthermore, our data demonstrate that type 1 diabetes is associated with altered EPC function and that these changes are observed even though the EPCs were cultured for 4 days in a normoglycemic environment. 

Phrase: "Furthermore,"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that type 1 diabetes"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "is"

Phrase: "associated with altered EPC function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C1292719:Associated function [Functional Concept]
   760   C0031843:function [Physiologic Function]
   760   C0169014:EPC [Organophosphorus Compound,Pharmacologic Substance]
   760   C0392747:Altered [Functional Concept]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "that"

Phrase: "these changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "even"

Phrase: "though"

Phrase: "the EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "cultured for 4 days"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0439228:days [Temporal Concept]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737 E C0332173:/day [Temporal Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C0439505:/day [Temporal Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "in a normoglycemic environment."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014406:Environment [Spatial Concept]
Processing 00000000.tx.126: To begin to investigate whether these functional changes are reflected in the gene expression profiles of the diabetic EPCs, we have performed preliminary Affymetrix DNA microarray analyses. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "these functional changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0205245:Functional [Functional Concept]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   861   C0542341:Functional [Functional Concept]
   861   C2700217:Functional [Conceptual Entity]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "reflected in the gene expression profiles of the diabetic EPCs,"
Meta Candidates (Total=19; Excluded=4; Pruned=0; Remaining=15)
   770   C1956267:Gene Expression Profiles [Quantitative Concept]
   754 E C1449575:gene expression profile [Laboratory Procedure]
   753   C0017262:Gene Expression [Genetic Function]
   753   C0038250:Progenitor Cells [Cell]
   751   C0225336:Endothelial Cells [Cell]
   736   C0007634:Cells [Cell]
   736   C0014257:Endothelial [Tissue]
   736   C0017337:Gene [Gene or Genome]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   736   C0241863:DIABETIC [Finding]
   736   C0558058:reflected [Mental Process]
   736   C0870134:Progenitor [Family Group]
   736   C3282337:Cells [Cell]
   734   C1861886:CELL Gene [Gene or Genome]
   703 E C1269647:Cell [Cell]
   703 E C1704653:Cell [Medical Device]
   703 E C1948049:Cell [Spatial Concept]
   703   C1979963:Profile [Laboratory Procedure]
   703   C2003903:Profile [Functional Concept]

Phrase: "we"

Phrase: "have"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "preliminary Affymetrix DNA microarray analyses."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   873   C1522053:DNA Microarray Analysis [Molecular Biology Research Technique]
   836   C0200898:DNA analysis [Laboratory Procedure]
   823   C1449575:Microarray Analysis [Laboratory Procedure]
   771   C0002778:Analysis [Laboratory Procedure]
   771   C0936012:Analysis [Research Activity]
   771   C1524024:analysis [Functional Concept]
Processing 00000000.tx.127: Indeed, we observed extensive differential gene expression in patient-derived cultured EPCs compared with control subjects. 

Phrase: "Indeed,"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "extensive differential gene expression in patient-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1519516:Differential Gene Expression [Genetic Function]
   790   C0017262:Gene Expression [Genetic Function]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "derived"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1441547:Derived [Qualitative Concept]
  1000   C3245521:derived [Idea or Concept]

Phrase: "cultured EPCs"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   902   C0007600:cultured cells [Cell]
   902   C0007635:Cultured Cells [Cell]
   902   C3282338:Cells, Cultured [Cell]
   875   C0225336:Endothelial Cells [Cell]
   861   C0038250:Progenitor Cells [Cell]
   812   C0007634:Cells [Cell]
   812   C0014257:Endothelial [Tissue]
   812   C0870134:Progenitor [Family Group]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "compared with control subjects."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]
Processing 00000000.tx.128: Interestingly, many of these alterations have been reported to be associated with diabetes in general, hyperglycemia, or oxidative stress such as plasminogen activator inhibitor 1 (15) and osteopontin (16). 

Phrase: "Interestingly,"

Phrase: "many of these alterations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439064:Many [Quantitative Concept]
   770   C0747726:many [Conceptual Entity]
   737   C1515926:Alteration [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "associated with diabetes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in general, hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "or"

Phrase: "oxidative stress such as plasminogen activator inhibitor 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   744   C0038435:Stress [Finding]
   744   C0311404:Oxidative [Functional Concept]

Phrase: "(15"

Phrase: ")"

Phrase: "and"

Phrase: "osteopontin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0069676:osteopontin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420369:OSTEOPONTIN [Gene or Genome]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.129: This demonstrates that EPCs may function as "bio-sensors," translating metabolic cues into altered gene expression. 

Phrase: "This"

Phrase: "demonstrates"

Phrase: "that EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "function"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]

Phrase: "as ""bio-sensors,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0183210:sensors [Medical Device]
   793 E C1705193:Sensor [Manufactured Object]

Phrase: """"

Phrase: "translating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040710:Translating [Occupational Activity]

Phrase: "metabolic cues into altered gene expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0010439:Cues [Idea or Concept]
Processing 00000000.tx.130: How the EPCs "remember" its metabolic descent in culture is unknown and needs further investigation. 

Phrase: "How"

Phrase: "the EPCs """
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "remember"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679062:remember [Mental Process]

Phrase: """"

Phrase: "its metabolic descent in culture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680043:descent [Family Group]

Phrase: "is"

Phrase: "unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "and"

Phrase: "needs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "further investigation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C1261322:Investigation [Health Care Activity]
   861   C1552578:investigation [Idea or Concept]
   789 E C1517586:Investigational [Qualitative Concept]
   789 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.131: Taken together, we demonstrate that EPCs cultured from type 1 diabetic patients are reduced in number and function. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "we"

Phrase: "demonstrate"

Phrase: "that EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "cultured from type 1 diabetic patients"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0441729:Type 1 [Classification]
   767   C1550335:Patient type [Classification]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0241863:DIABETIC [Finding]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]
   719   C0010453:Culture [Idea or Concept]
   719   C0220814:culture [Functional Concept]
   719   C0430400:Culture [Laboratory Procedure]
   719   C2242979:Culture [Laboratory Procedure]

Phrase: "are"

Phrase: "reduced in number"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0237753:*Number [Quantitative Concept]
   790   C0392756:Reduced [Qualitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "function."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.132: As a consequence, EPC dysfunction may reduce the vascular regenerative potential of this patient group and thereby contribute to the pathogenesis of vascular complications in type 1 diabetes. 

Phrase: "As a consequence,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0686907:Consequence [Functional Concept]

Phrase: "EPC dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "may"

Phrase: "reduce"

Phrase: "the vascular regenerative potential of this patient group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "thereby"

Phrase: "contribute to the pathogenesis of vascular complications"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0009566:Complications [Pathologic Function]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1171258:complications [Pathologic Function]
   748   C1558950:VASCULAR [Finding]
   748   C1801960:Vascular [Qualitative Concept]
   748   C1880177:Contribute [Activity]
   714 E C2362589:Complication [Idea or Concept]

Phrase: "in type 1 diabetes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.133: Finally, the notion that EPC dysfunction exists in certain patient categories, such as type 1 diabetes, may have implications for currently explored cell-based clinical strategies to enhance tissue perfusion in patients with ischemic coronary and peripheral artery disease (17,18). 

Phrase: "Finally,"

Phrase: "the notion"

Phrase: "that EPC dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "exists in certain patient categories,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0030705:*^patient [Patient or Disabled Group]
   760   C0683312:Categories [Intellectual Product]
   760   C2987476:Exist [Conceptual Entity]
   726 E C1555713:category [Idea or Concept]

Phrase: "such as type 1 diabetes,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0011854:Type 1 diabetes [Disease or Syndrome]
   913   C1320657:type diabetes [Finding]
   901   C0441729:Type 1 [Classification]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0332307:Type [Qualitative Concept]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "may"

Phrase: "have"

Phrase: "implications for currently explored cell-based clinical strategies to"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "tissue perfusion in patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0429877:Tissue perfusion [Finding]
   770   C0031001:Perfusion [Therapeutic or Preventive Procedure]

Phrase: "with ischemic coronary"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018787:coronary [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "peripheral artery disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C1704436:Peripheral Artery Disease [Disease or Syndrome]
   976 E C0085096:peripheral arterial disease [Disease or Syndrome]
   901   C0489868:Peripheral artery [Body Part, Organ, or Organ Component]
   901   C0852949:artery disease [Disease or Syndrome]
   827   C0003842:Artery [Body Part, Organ, or Organ Component]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0205100:Peripheral [Spatial Concept]
   827   C0226004:artery [Body System]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C0221464:Arterial [Spatial Concept]

Phrase: "(17,"

Phrase: "18"

Phrase: ")."
Processing 00000000.tx.134: EPCs or MNCs isolated from these patients for autologous cell transplantation may retain their dysfunctional characteristics in vivo and as a consequence display a reduced capacity to augment therapeutic neovascularization. 

Phrase: "EPCs"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "or"

Phrase: "MNCs"

Phrase: "isolated from these patients"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205409:Isolated [Functional Concept]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "for autologous cell transplantation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0040736:Transplantation, Autologous [Therapeutic or Preventive Procedure]
   901   C0206153:Cell Transplantation [Therapeutic or Preventive Procedure]
   827   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   827   C0040733:transplantation [Functional Concept]

Phrase: "may"

Phrase: "retain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "their dysfunctional characteristics"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521970:Characteristics [Qualitative Concept]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and as a consequence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0686907:Consequence [Functional Concept]
   770   C1515981:And [Idea or Concept]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "a reduced capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1516240:Capacity [Quantitative Concept]

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "therapeutic neovascularization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027686:Neovascularisation [Pathologic Function]
Processing 00000000.tx.135: Therefore, it could be useful to set progenitor quality criteria and perform EPC function tests (such as assays for angiogenic growth factor secretion, adhesion, or migration) in order to obtain optimal cells for transplantation.  

Phrase: "Therefore,"

Phrase: "it"

Phrase: "could"

Phrase: "be"

Phrase: "useful to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0042153:use [Functional Concept]
   789   C0457083:Use [Functional Concept]
   789   C1947944:Use [Intellectual Product]

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "progenitor quality criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0243161:criteria [Intellectual Product]

Phrase: "and"

Phrase: "perform"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0884358:Perform [Functional Concept]
  1000   C2947996:Perform [Pharmacologic Substance]

Phrase: "EPC function tests"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0022885:Tests [Laboratory Procedure]
   827   C0392366:Tests [Intellectual Product]
   793 E C0039593:Test [Functional Concept]

Phrase: "("

Phrase: "such as assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "for angiogenic growth factor secretion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   708   C0002976:Angiogenic Factor [Biologically Active Substance]

Phrase: "adhesion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001511:Adhesion [Pathologic Function]
  1000   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "or"

Phrase: "migration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0600210:Migration [Social Behavior]
  1000   C1533574:Migration [Physiologic Function]
  1000   C1881827:MIGRATION [Phenomenon or Process]

Phrase: ")"

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "optimal cells for transplantation."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   819   C0206153:cells transplantation [Therapeutic or Preventive Procedure]
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.136: ACKNOWLEDGMENTS  Supported by the Netherlands Heart Foundation, The Hague, by Grants 2000.019 and 2002B157. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "Supported by the Netherlands Heart Foundation,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0027778:The Netherlands [Geographic Area]
           Netherlands
   753   C0016617:Foundation [Organization]
   753   C0018787:Heart [Body Part, Organ, or Organ Component]
   753   C1281570:Heart [Body Part, Organ, or Organ Component]
   753   C1521721:Supported [Conceptual Entity]
   742   C0225810:HEART, BASE [Body Location or Region]
   719 E C0183683:Support [Medical Device]

Phrase: "The Hague,"

Phrase: "by Grants 2000.019"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0018173:Grants [Quantitative Concept]
   793 E C1548284:Grant [Idea or Concept]

Phrase: "and"

Phrase: "2002B157."
Processing 00000000.tx.137: B.B. is supported by a fellowship of the Dutch Academy of Arts and Sciences. 

Phrase: "B.B."

Phrase: "is"

Phrase: "supported by a fellowship of the Dutch Academy of Arts"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   739   C0000876:Academy [Organization]
   739   C0003826:Arts [Occupation or Discipline]
   739   C0013331:Dutch [Population Group]
   739   C0015770:Fellowship [Educational Activity]
   739   C1521721:Supported [Conceptual Entity]
   739   C3538895:ARTS [Gene or Genome]
   739   C3538896:ARTS [Amino Acid, Peptide, or Protein]
   706 E C0183683:Support [Medical Device]
   706 E C0220786:ART [Manufactured Object]

Phrase: "and"

Phrase: "Sciences."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Sciences [Occupation or Discipline]
Processing 00000000.tx.138: M.C.V. is supported by the Netherlands Organization for Scientific Research (NWO Grant 016.036.041). 

Phrase: "M.C.V."

Phrase: "is"

Phrase: "supported by the Netherlands Organization"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0027778:The Netherlands [Geographic Area]
           Netherlands
   760   C0029237:Organisation [Physiologic Function]
   760   C0029246:Organization [Organization]
   760   C0220885:organization [Qualitative Concept]
   760   C1300196:Organization [Functional Concept]
   760   C1521721:Supported [Conceptual Entity]
   760   C1522486:Organization [Professional or Occupational Group]
   726 E C0183683:Support [Medical Device]

Phrase: "for Scientific Research"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0683933:scientific research [Research Activity]
   861   C0035168:research [Research Activity]
   861   C0036397:Scientific [Occupation or Discipline]
   861   C0242481:Research [Research Activity]

Phrase: "(NWO Grant 016.036.041"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0018173:Grant [Quantitative Concept]
   804   C1548284:Grant [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.139: F.J.T.S. is supported by the Dutch Academy of Arts and Sciences, the Bekales Foundation, and the Anna and Maurits de Cock Foundation. 

Phrase: "F.J."

Phrase: "T.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603360:T' [Clinical Attribute]

Phrase: "is"

Phrase: "supported by the Dutch Academy of Arts"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0000876:Academy [Organization]
   748   C0003826:Arts [Occupation or Discipline]
   748   C0013331:Dutch [Population Group]
   748   C1521721:Supported [Conceptual Entity]
   748   C3538895:ARTS [Gene or Genome]
   748   C3538896:ARTS [Amino Acid, Peptide, or Protein]
   714 E C0183683:Support [Medical Device]
   714 E C0220786:ART [Manufactured Object]

Phrase: "and"

Phrase: "Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Sciences [Occupation or Discipline]

Phrase: "the Bekales Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "the Anna"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1014208:Anna [Plant]

Phrase: "and"

Phrase: "Maurits de Cock Foundation."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]
Processing 00000000.tx.140: We are grateful to Dr. 

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Dr."
Processing 00000000.tx.141: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.142: Murohara from the Nagoya University Graduate School of Medicine for teaching us how to culture EPCs. 

Phrase: "Murohara from the Nagoya University Graduate School of Medicine"

Phrase: "for teaching"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039401:Teaching [Educational Activity]
  1000   C0220924:teaching [Educational Activity]
  1000   C1548344:Teaching [Intellectual Product]

Phrase: "us how to culture EPCs."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   778   C0038250:Progenitor Cells [Cell]
   774   C0007585:cells culture [Laboratory Procedure]
   774   C0225336:Endothelial Cells [Cell]
   748   C0007634:Cells [Cell]
   748   C0010453:Culture [Idea or Concept]
   748   C0014257:Endothelial [Tissue]
   748   C0220814:culture [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0870134:Progenitor [Family Group]
   748   C2242979:Culture [Laboratory Procedure]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.143: Address correspondence and reprint requests to Anton-Jan van Zonneveld, PhD, Department of Vascular Medicine, University Medical Center Utrecht, G02.402, Heidelberglaan 100, 3584 CX, Utrecht, Netherlands. 

Phrase: "Address correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "reprint"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3273171:Reprint [Intellectual Product]

Phrase: "requests to Anton-Jan van Zonneveld,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0557775:Van [Manufactured Object]
   753   C0686900:request [Functional Concept]
   753   C1272683:Request [Functional Concept]
   753   C1522634:Request [Intellectual Product]

Phrase: "PhD,"

Phrase: "Department of Vascular Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "University Medical Center Utrecht,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0000872:University Medical Center [Health Care Related Organization,Manufactured Object]

Phrase: "G02.402,"

Phrase: "Heidelberglaan 100,"

Phrase: "3584 CX,"

Phrase: "Utrecht,"

Phrase: "Netherlands."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027778:Netherlands [Geographic Area]
Processing 00000000.tx.144: E-mail: a.j.vanzonneveld{at}azu.nl Received for publication July 17, 2003 and accepted in revised form September 25, 2003 EC, endothelial cell; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "a.j.vanzonneveld{at}azu.nl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0027778:NL [Geographic Area]
   799   C0560008:nL [Quantitative Concept]

Phrase: "Received for publication July 17,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2003"

Phrase: "and"

Phrase: "accepted in revised form September 25,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1272684:Accepted [Qualitative Concept]
   753   C1522492:Form [Functional Concept]
   753   C1527075:Revised [Therapeutic or Preventive Procedure]
   753   C1548435:Accepted [Idea or Concept]
   719 E C1548601:Accept [Idea or Concept]

Phrase: "2003 EC,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0225336:Endothelial cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "endothelial cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0225336:Endothelial cell [Cell]
   861   C0007634:Cell [Cell]
   861   C0014257:Endothelial [Tissue]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.145: EPC, endothelial progenitor cell; 

Phrase: "EPC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0169014:EPC [Organophosphorus Compound,Pharmacologic Substance]

Phrase: "endothelial progenitor cell"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   913   C0225336:Endothelial cell [Cell]
   901   C0038250:Progenitor Cell [Cell]
   827   C0007634:Cell [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.146: FITC, fluorescein isothiocyanate; 

Phrase: "FITC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0124209:Isothiocyanate [Organic Chemical]
   861   C0206359:isothiocyanate [Organic Chemical]

Phrase: "fluorescein isothiocyanate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0060520:Fluorescein [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0124209:Isothiocyanate [Organic Chemical]
   861   C0206359:isothiocyanate [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.147: HUVEC, human umbilical vein EC; 

Phrase: "HUVEC,"

Phrase: "human umbilical vein EC"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   897   C0427861:human cell [Laboratory or Test Result]
   840   C0041637:Umbilical vein [Embryonic Structure]
   840   C0221313:Umbilical vein [Embryonic Structure]
   840   C0225336:Endothelial cell [Cell]
   840   C1280193:Umbilical vein [Body Part, Organ, or Organ Component]
   804   C0007634:Cell [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0041638:Umbilical [Body Part, Organ, or Organ Component]
   804   C0042449:Vein [Body Part, Organ, or Organ Component]
   804   C0086418:Human [Human]
   804   C1179027:Vein Endothelium [Tissue]
   804   C1269647:Cell [Cell]
   804   C1278960:Vein [Body Part, Organ, or Organ Component]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.148: MNC, mononuclear cell; 

Phrase: "MNC,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0806987:mononuclear cell [Cell]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1513475:Mononuclear [Clinical Attribute]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "mononuclear cell"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0806987:mononuclear cell [Cell]
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1513475:Mononuclear [Clinical Attribute]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ";"
Processing 00000000.tx.149: PB, peripheral blood; 

Phrase: "PB,"

Phrase: "peripheral blood"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
  1000   C0229664:peripheral blood [Body Substance]
           Blood
   958 E C0150936:Peripheral Blood Vessel [Body Part, Organ, or Organ Component]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0205100:Peripheral [Spatial Concept]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.150: UEA, Ulex europaeus agglutinin  REFERENCES TOP ABSTRACT RESEARCH DESIGN AND METHODS RESULTS DISCUSSION REFERENCES  Sheetz MJ, King GL: Molecular understanding of hyperglycemias adverse effects for diabetic complications. 

Phrase: "UEA,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0996858:Ulex europaeus [Plant]
   861   C3486655:ULEX EUROPAEUS [Pharmacologic Substance]
   812   C0001804:Agglutinin [Immunologic Factor]
   812   C0996857:Ulex [Plant]
   812   C1524063:Using [Functional Concept]
   779 E C0042153:use [Functional Concept]
   779 E C0457083:Use [Functional Concept]
   779 E C1947944:Use [Intellectual Product]

Phrase: "Ulex europaeus agglutinin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0996858:Ulex europaeus [Plant]
   901   C3486655:ULEX EUROPAEUS [Pharmacologic Substance]
   827   C0001804:Agglutinin [Immunologic Factor]
   827   C0996857:Ulex [Plant]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT RESEARCH DESIGN"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0035171:Research Design [Research Activity]
   812   C0035168:research [Research Activity]
   812   C0242481:Research [Research Activity]
   812   C1707689:Design [Activity]
   812   C2983265:DESIGN [Intellectual Product]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Sheetz MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "King"

Phrase: "GL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0018229:GL [Geographic Area]
  1000   C1423073:GL [Gene or Genome]
  1000   C1427674:GL [Gene or Genome]

Phrase: ":"

Phrase: "Molecular understanding of hyperglycemias adverse effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162340:Understanding [Mental Process]

Phrase: "for diabetic complications."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0342257:Diabetic Complications [Pathologic Function]
   861   C0009566:Complications [Pathologic Function]
   861   C1171258:complications [Pathologic Function]
   827 E C2362589:Complication [Idea or Concept]
   777 E C0231242:Complicated [Functional Concept]
Processing 00000000.tx.151: JAMA288 :2579 2588,2002[Abstract/Free FullText] Waltenberger J: Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. 

Phrase: "JAMA288"

Phrase: ":"

Phrase: "2579 2588,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Waltenberger J"

Phrase: ":"

Phrase: "Impaired collateral vessel development in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]

Phrase: ":"

Phrase: "potential cellular mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "therapeutic implications."
Processing 00000000.tx.152: Cardiovasc Res49 :554 560,2001[Medline] Abaci A, Oguzhan A, Kahraman S, Eryol NK, Unal S, Arinc H, Ergin A: Effect of diabetes mellitus on formation of coronary collateral vessels. 

Phrase: "Cardiovasc Res49"

Phrase: ":"

Phrase: "554 560,"

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Abaci A,"

Phrase: "Oguzhan A,"

Phrase: "Kahraman S,"

Phrase: "Eryol NK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022688:NK [Cell]

Phrase: "Unal S,"

Phrase: "Arinc H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ergin A"

Phrase: ":"

Phrase: "Effect of diabetes mellitus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of coronary collateral vessels."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   913   C0010075:Coronary Vessels [Body Part, Organ, or Organ Component]
   901   C1185727:collateral vessels [Body Part, Organ, or Organ Component]
   827   C0005847:Vessels [Body Part, Organ, or Organ Component]
   827   C1275670:Collateral [Body Part, Organ, or Organ Component]
   827   C1948058:Collateral [Spatial Concept]
   793 E C1511228:Vessel [Tissue]
   755 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.153: Circulation99 :2239 2242,1999[Abstract/Free FullText] Asahara T, Murohara T, Sullivan A, Silver M, van der ZR, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. 

Phrase: "Circulation99"

Phrase: ":"

Phrase: "2239 2242,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "] Asahara T,"

Phrase: "Murohara T,"

Phrase: "Sullivan A,"

Phrase: "Silver M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "van der ZR,"

Phrase: "Li T,"

Phrase: "Witzenbichler B,"

Phrase: "Schatteman G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Isner JM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: ":"

Phrase: "Isolation of putative progenitor endothelial cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0007616:cells isolation [Laboratory Procedure]
   753   C0204727:Isolation [Therapeutic or Preventive Procedure]
   753   C0205409:Isolation [Functional Concept]
   753   C0220862:isolation [Laboratory Procedure]

Phrase: "for angiogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0302600:Angiogenesis [Organ or Tissue Function]
  1000   C1519670:angiogenesis [Neoplastic Process]
Processing 00000000.tx.154: Science275 :964 967,1997[Abstract/Free FullText] Hristov M, Erl W, Weber PC: Endothelial progenitor cells: mobilization, differentiation, and homing. 

Phrase: "Science275"

Phrase: ":"

Phrase: "964 967,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hristov M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Erl W,"

Phrase: "Weber PC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540812:PC [Gene or Genome]

Phrase: ":"

Phrase: "Endothelial progenitor cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "mobilization,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185112:Mobilisation [Therapeutic or Preventive Procedure]
  1000   C0300926:mobilization [Functional Concept]

Phrase: "differentiation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0007589:Differentiation [Cell Function]
  1000   C1511938:Differentiation [Clinical Attribute]
  1000   C2945687:Differentiation [Functional Concept]
   928 E C0205615:Differentiated [Qualitative Concept]

Phrase: "and"

Phrase: "homing."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0442519:Home [Conceptual Entity]
Processing 00000000.tx.155: Arterioscler ThrombVasc Biol23 :1185 1189,2003[Abstract/Free FullText] Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. 

Phrase: "Arterioscler ThrombVasc Biol23"

Phrase: ":"

Phrase: "1185 1189,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Vasa M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fichtlscherer S,"

Phrase: "Aicher A,"

Phrase: "Adler K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Urbich C,"

Phrase: "Martin H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Zeiher"

Phrase: "AM"

Phrase: ","

Phrase: "Dimmeler S"

Phrase: ":"

Phrase: "Number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "migratory activity of circulating endothelial progenitor cells inversely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "correlate with risk factors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0035648:risk factors [Quantitative Concept]
   833   C1553898:risk factors [Idea or Concept]
   770   C0035647:Risk [Qualitative Concept]
   737   C1521761:Factor [Functional Concept]
   737   C2827422:Factor [Conceptual Entity]

Phrase: "for coronary artery disease."
Meta Candidates (Total=15; Excluded=4; Pruned=0; Remaining=11)
  1000   C0010054:coronary artery disease [Disease or Syndrome]
  1000   C0010068:Coronary (artery) disease [Disease or Syndrome]
           Coronary Disease
  1000   C1956346:Coronary Artery Disease [Disease or Syndrome]
   901   C0205042:Coronary artery [Body Part, Organ, or Organ Component]
   901   C0852949:artery disease [Disease or Syndrome]
   901   C1269008:Coronary artery [Body Part, Organ, or Organ Component]
   827   C0003842:Artery [Body Part, Organ, or Organ Component]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0018787:coronary [Body Part, Organ, or Organ Component]
   827   C0226004:artery [Body System]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C0221464:Arterial [Spatial Concept]
Processing 00000000.tx.156: Circ Res89 :E1 E7,2001[Medline] Schatteman GC, Hanlon HD, Jiao C, Dodds SG, Christy BA: Blood-derived angioblasts accelerate blood-flow restoration in diabetic mice. 

Phrase: "Circ Res89"

Phrase: ":"

Phrase: "E1 E7,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1335333:E7 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "2001"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Schatteman GC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: "Hanlon HD,"

Phrase: "Jiao C,"

Phrase: "Dodds SG,"

Phrase: "Christy BA"

Phrase: ":"

Phrase: "Blood-derived angioblasts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1515989:Angioblast [Cell]

Phrase: "accelerate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:accelerate [Functional Concept]

Phrase: "blood-flow restoration in diabetic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449982:Restoration [Intellectual Product]
   742   C0596199:blood vessel restoration [Therapeutic or Preventive Procedure]
Processing 00000000.tx.157: J Clin Invest106 :571 578,2000[Abstract/Free FullText] Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, Levine JP, Gurtner GC: Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. 

Phrase: "J Clin Invest106"

Phrase: ":"

Phrase: "571 578,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tepper OM,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0028971:OM [Geographic Area]
   861   C1705272:OM [Idea or Concept]

Phrase: "Galiano RD,"

Phrase: "Capla JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Kalka C,"

Phrase: "Gagne PJ,"

Phrase: "Jacobowitz GR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "Levine JP,"

Phrase: "Gurtner GC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3537453:GC [Gene or Genome]

Phrase: ":"

Phrase: "Human endothelial progenitor cells from type II diabetics"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   782   C1519715:Type II Cell [Cell]
   770   C0038250:Progenitor Cells [Cell]
   767   C0225336:Endothelial Cells [Cell]
   767   C0427861:Human cells [Laboratory or Test Result]
   767   C0449475:cells type [Intellectual Product]
   750 E C0007634:Cell Type [Cell]
           Cells
   744   C0014257:Endothelial [Tissue]
   744   C0870134:Progenitor [Family Group]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "impaired proliferation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0334094:Proliferation [Pathologic Function]
   861   C1514485:Proliferation [Functional Concept]

Phrase: "adhesion,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001511:Adhesion [Pathologic Function]
  1000   C0175633:Adhesion [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "incorporation into vascular structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]
Processing 00000000.tx.158: Circulation106 :2781 2786,2002[Abstract/Free FullText] Hill JM, Zalos G, Halcox JP, Schenke, WH, Waclawiw MA, Quyyumi AA, Finkel T: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. 

Phrase: "Circulation106"

Phrase: ":"

Phrase: "2781 2786,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hill JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Zalos G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Halcox JP,"

Phrase: "Schenke,"

Phrase: "WH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349143:Wh [Quantitative Concept]

Phrase: "Waclawiw MA,"

Phrase: "Quyyumi AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Finkel T"

Phrase: ":"

Phrase: "Circulating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0175630:Circulating [Functional Concept]

Phrase: "endothelial progenitor cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C0225336:Endothelial Cells [Cell]
   901   C0038250:Progenitor Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0014257:Endothelial [Tissue]
   827   C0870134:Progenitor [Family Group]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "vascular function,"
Meta Candidates (Total=18; Excluded=10; Pruned=0; Remaining=8)
  1000   C0232337:Vascular function [Clinical Attribute]
   950 E C0005811:blood function [Organ or Tissue Function]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1558950:VASCULAR [Finding]
   861   C1705273:Function [Intellectual Product]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "and"

Phrase: "cardiovascular risk."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007226:Cardiovascular [Body System]
   861   C0035647:Risk [Qualitative Concept]
Processing 00000000.tx.159: N Engl J Med348 :593 600,2003[Abstract/Free FullText] Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, Eguchi H, Onitsuka I, Matsui K, Imaizumi T: Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. 

Phrase: "N Engl J Med348"

Phrase: ":"

Phrase: "593 600,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Murohara T,"

Phrase: "Ikeda H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Duan J,"

Phrase: "Shintani S,"

Phrase: "Sasaki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Eguchi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Onitsuka I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Matsui K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Imaizumi T"

Phrase: ":"

Phrase: "Transplanted cord blood-derived endothelial precursor cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   861   C0005773:Blood Cells [Cell]
   860   C0206152:transplant cell [Cell]
   830   C1257792:Vascular Endothelial Cells [Cell]
   829   C0225336:Endothelial Cells [Cell]
   817 E C2328697:Hemal cell [Cell]
   801   C0018956:precursor cell [Cell]
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "augment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205217:augment [Quantitative Concept]

Phrase: "postnatal neovascularization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027686:Neovascularisation [Pathologic Function]
Processing 00000000.tx.160: J Clin Invest105 :1527 1536,2000[Abstract/Free FullText] Hetts, SW: To die or not to die: an overview of apoptosis and its role in disease. 

Phrase: "J Clin Invest105"

Phrase: ":"

Phrase: "1527 1536,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hetts,"

Phrase: "SW"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1420193:SW [Gene or Genome]
  1000   C1832169:SW [Body System]
  1000   C3538902:SW [Gene or Genome]

Phrase: ":"

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "die"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   944   C0011065:Expired [Organism Function]
   944   C0231800:Expired [Organ or Tissue Function]
   944   C1704631:Expire [Idea or Concept]
   916 E C0184532:dying [Organism Function]
   916 E C1546956:Died [Finding]
   916 E C1553404:terminated [Idea or Concept]
   916 E C2348570:Terminated [Functional Concept]

Phrase: "or"

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "die"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   944   C0011065:Expired [Organism Function]
   944   C0231800:Expired [Organ or Tissue Function]
   944   C1704631:Expire [Idea or Concept]
   916 E C0184532:dying [Organism Function]
   916 E C1546956:Died [Finding]
   916 E C1553404:terminated [Idea or Concept]
   916 E C2348570:Terminated [Functional Concept]

Phrase: ":"

Phrase: "an overview of apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0814812:overview [Intellectual Product]

Phrase: "and"

Phrase: "its role in disease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.161: JAMA279 :300 307,1998[Abstract/Free FullText] Greene DA, Stevens MJ, Obrosova I, Feldman EL: Glucose-induced oxidative stress and programmed cell death in diabetic neuropathy. 

Phrase: "JAMA279"

Phrase: ":"

Phrase: "300 307,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "] Greene DA,"

Phrase: "Stevens MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Obrosova I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Feldman EL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416870:EL [Gene or Genome]
   861   C1823249:EL [Gene or Genome]

Phrase: ":"

Phrase: "Glucose-induced oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   812   C0038435:Stress [Finding]
   812   C0311404:Oxidative [Functional Concept]
   741 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "programmed cell death in diabetic neuropathy."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0162638:Programmed Cell Death [Cell Function]
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.162: Eur J Pharmacol375 :217 223,1999[Medline] Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert, RA, Bowen-Pope DF: Endothelial cells of hematopoietic origin make a significant contribution to adult blood vessel formation. 

Phrase: "Eur J Pharmacol375"

Phrase: ":"

Phrase: "217 223,"

Phrase: "1999"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Crosby JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "Kaminski"

Phrase: "WE,"

Phrase: "Schatteman G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Martin PJ,"

Phrase: "Raines EW,"

Phrase: "Seifert,"

Phrase: "RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538806:Ra [Spatial Concept]

Phrase: "Bowen-Pope DF"

Phrase: ":"

Phrase: "Endothelial cells of hematopoietic origin"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0225336:Endothelial Cells [Cell]
   781   C2323499:Hematopoietic cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0014257:Endothelial [Tissue]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "a significant contribution to adult blood vessel formation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contribution [Activity]
Processing 00000000.tx.163: Circ Res87 :728 730,2000[Abstract/Free FullText] Rehman J, Li J, Orschell CM, March KL: Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. 

Phrase: "Circ Res87"

Phrase: ":"

Phrase: "728 730,"

Phrase: "2000"

Phrase: "[Abstract/Free FullText"

Phrase: "] Rehman J,"

Phrase: "Li J,"

Phrase: "Orschell CM,"

Phrase: "March KL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1366480:KL [Gene or Genome]
   861   C1416656:KL [Gene or Genome]

Phrase: ":"

Phrase: "Peripheral blood ""endothelial progenitor cells"""
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   894   C0005773:Peripheral blood cell [Cell]
           Blood Cells
   855   C1257792:Vascular Endothelial Cells [Cell]
   853   C0225336:Endothelial Cells [Cell]
   840   C0038250:Progenitor Cells [Cell]
   831 E C2328697:Hemal cell [Cell]
   804   C0007634:Cells [Cell]
   804   C0014257:Endothelial [Tissue]
   804   C0870134:Progenitor [Family Group]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
   762   C1706972:Blood Vessel Endothelium [Tissue]
   754 E C0014261:Endothelium, Vascular [Tissue]

Phrase: "are"

Phrase: "derived from monocyte/macrophages"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   868   C0024432:Monocyte-Derived Macrophages [Cell]
           Macrophages
   770   C0026473:Monocyte [Cell]
   770   C1441547:Derived [Qualitative Concept]
   770   C1546706:Macrophages [Intellectual Product]
   770   C1550652:Macrophages [Body Substance]
   770   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "secrete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:secrete [Cell Function]

Phrase: "angiogenic growth factors."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0018284:Growth Factors [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896   C0002976:Angiogenic Factor [Biologically Active Substance]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
   793   C1521761:Factor [Functional Concept]
   793   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.164: Circulation107 :1164 1169,2003[Abstract/Free FullText] Mason RM, Wahab NA: Extracellular matrix metabolism in diabetic nephropathy. 

Phrase: "Circulation107"

Phrase: ":"

Phrase: "1164 1169,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mason RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Wahab NA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597484:Na+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1272460:{NA} [Qualitative Concept]

Phrase: ":"

Phrase: "Extracellular matrix metabolism in diabetic nephropathy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0025519:Metabolism [Organism Function]
   753   C0025520:metabolism [Functional Concept]
Processing 00000000.tx.165: J Am Soc Nephrol14 :1358 1373,2003[Abstract/Free FullText] Chen NX, Moe SM: Arterial calcification in diabetes. 

Phrase: "J"

Phrase: "Am"

Phrase: "Soc Nephrol14"

Phrase: ":"

Phrase: "1358 1373,"

Phrase: "2003"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chen NX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0445085:NX [Finding]

Phrase: "Moe SM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: ":"

Phrase: "Arterial calcification in diabetes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C1168153:arterial calcification [Pathologic Function]
   770   C0006660:calcification [Organ or Tissue Function]
   770   C0175895:Calcification [Qualitative Concept]
   770   C1533591:Calcification [Finding,Organ or Tissue Function]
   770   C1879982:CALCIFICATION [Phenomenon or Process]
Processing 00000000.tx.166: Curr Diab Rep3 :28 32,2003[Medline] Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM: Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). 

Phrase: "Curr Diab Rep3"

Phrase: ":"

Phrase: "28 32,"

Phrase: "2003"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Assmus B,"

Phrase: "Schachinger V,"

Phrase: "Teupe C,"

Phrase: "Britten M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lehmann R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dobert N,"

Phrase: "Grunwald F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Aicher A,"

Phrase: "Urbich C,"

Phrase: "Martin H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hoelzer D,"

Phrase: "Dimmeler S,"

Phrase: "Zeiher"

Phrase: "AM"

Phrase: ":"

Phrase: "Transplantation of Progenitor Cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C0206153:cells transplantation [Therapeutic or Preventive Procedure]
   770   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   770   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   770   C0040733:transplantation [Functional Concept]

Phrase: "and"

Phrase: "Regeneration Enhancement in Acute Myocardial Infarction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: "(TOPCARE-AMI"

Phrase: ")."
Processing 00000000.tx.167: Circulation106 :3009 3017,2002[Abstract/Free FullText] Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T: Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. 

Phrase: "Circulation106"

Phrase: ":"

Phrase: "3009 3017,"

Phrase: "2002"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tateishi-Yuyama E,"

Phrase: "Matsubara H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Murohara T,"

Phrase: "Ikeda U,"

Phrase: "Shintani S,"

Phrase: "Masaki H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Amano K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kishimoto Y,"

Phrase: "Yoshimoto K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Akashi H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Shimada K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Iwasaka T,"

Phrase: "Imaizumi T"

Phrase: ":"

Phrase: "Therapeutic angiogenesis for patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0302600:Angiogenesis [Organ or Tissue Function]
   770   C1519670:angiogenesis [Neoplastic Process]

Phrase: "with limb ischaemia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C2945695:Limb ischaemia [Disease or Syndrome]
   861   C0022116:Ischaemia [Disease or Syndrome]
   789 E C0475224:Ischaemic [Functional Concept]

Phrase: "by autologous transplantation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040736:Transplantation, Autologous [Therapeutic or Preventive Procedure]
   861   C0029216:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040732:Transplantation [Therapeutic or Preventive Procedure]
   861   C0040733:transplantation [Functional Concept]

Phrase: "of bone-marrow cells"
Meta Candidates (Total=21; Excluded=9; Pruned=0; Remaining=12)
  1000   C0005955:Bone Marrow Cells [Cell]
   913   C0222677:Bone cells [Cell]
   901   C0005953:Bone Marrow [Tissue]
   896 E C0029432:Bone cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0086590:Marrow [Food]
   827   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
   827   C0376152:Marrow [Body Part, Organ, or Organ Component]
   827   C0391978:Bone [Tissue]
   827   C1266908:Bone [Body Part, Organ, or Organ Component]
   827   C1266909:Bone [Body System]
   827   C1546708:Marrow [Intellectual Product]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
   771 E C0001629:Medullary [Body Part, Organ, or Organ Component]
   771 E C0025148:Medullary [Body Part, Organ, or Organ Component]
   771 E C1550278:Medullary [Body Part, Organ, or Organ Component]
   755 E C0443157:Bony [Functional Concept]
   743 E C0330477:Marrows [Plant]

Phrase: ":"

Phrase: "a pilot study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0031928:Pilot Study [Research Activity]
   861   C0473169:Pilot [Professional or Occupational Group]
   861   C0557651:Study [Manufactured Object]
   861   C1414316:PILOT [Gene or Genome]
   861   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "a randomised controlled trial."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
  1000   C0282440:randomized controlled trial [Intellectual Product,Research Activity]
  1000   C1096777:Randomized Controlled Trial [Intellectual Product,Research Activity]
   827   C0008976:Trial [Research Activity]
   827   C2587213:Controlled [Functional Concept]
   793 E C0243148:control [Qualitative Concept]
   793 E C1550141:Control [Substance]
   793 E C1882979:Control [Conceptual Entity]
   793 E C3274648:Control [Qualitative Concept]
Processing 00000000.tx.168: Lancet360 :427 435,2002[Medline]

Phrase: "Lancet360"

Phrase: ":"

Phrase: "427 435,"

Phrase: "2002"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

